# PeptideScanner evidence objects: Linaclotide

Every published version of the records placed with Linaclotide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/linaclotide.json. Selected public evidence only; not medical advice.

- Objects: 100
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct00730015-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT00730015

> PeptideScanner retained ClinicalTrials.gov record NCT00730015 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-01-30, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct00730015-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2013-01-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00730015-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct00730015-linaclotide-v1
- Content SHA-256: `9096b85a5f28a93a65eb2dab1cc3b0a646b245494533edaffc52b39d9f263e0a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00730015 ([`ctg-observation-nct00730015-2013-01-30-884c7667c3fe`](#source-ctg-observation-nct00730015-2013-01-30-884c7667c3fe))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00730015 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-01-30, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct00730015-2013-01-30-884c7667c3fe`](#source-ctg-observation-nct00730015-2013-01-30-884c7667c3fe))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00730015 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-01-30, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct00730015-2013-01-30-884c7667c3fe`](#source-ctg-observation-nct00730015-2013-01-30-884c7667c3fe))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00730015-2013-01-30-884c7667c3fe`](#source-ctg-observation-nct00730015-2013-01-30-884c7667c3fe))

### Sources

<a id="source-ctg-observation-nct00730015-2013-01-30-884c7667c3fe"></a>
- **ClinicalTrials.gov record NCT00730015 · retained source version 2013-01-30:884c7667c3fe191bd90ce57eb7895091bd40a34435c6384c41c332f091cdfe1f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00730015) (`ctg-observation-nct00730015-2013-01-30-884c7667c3fe`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00730015." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct00730015-linaclotide-v1 SHA-256: 9096b85a5f28a93a65eb2dab1cc3b0a646b245494533edaffc52b39d9f263e0a.

---

<a id="clinicaltrials-gov-nct00730171-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT00730171

> PeptideScanner retained ClinicalTrials.gov record NCT00730171 at 2026-07-30T21:12:47.419Z. Its registry update date was 2018-02-19, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct00730171-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-02-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00730171-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct00730171-linaclotide-v1
- Content SHA-256: `1816aadb2488f3396111b689fb6debbf7a1f3e5ba4d4f936c0d4931068e5fd0b`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00730171 ([`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`](#source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00730171 at 2026-07-30T21:12:47.419Z. Its registry update date was 2018-02-19, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`](#source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00730171 at 2026-07-30T21:12:47.419Z. Its registry update date was 2018-02-19, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`](#source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`](#source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe))

### Sources

<a id="source-ctg-observation-nct00730171-2018-02-19-000ab9dd65fe"></a>
- **ClinicalTrials.gov record NCT00730171 · retained source version 2018-02-19:000ab9dd65feb70bfb1714ee9240738c5005e75f16ad36580110336999d663b8** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00730171) (`ctg-observation-nct00730171-2018-02-19-000ab9dd65fe`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00730171." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct00730171-linaclotide-v1 SHA-256: 1816aadb2488f3396111b689fb6debbf7a1f3e5ba4d4f936c0d4931068e5fd0b.

---

<a id="clinicaltrials-gov-nct00765999-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT00765999

> PeptideScanner retained ClinicalTrials.gov record NCT00765999 at 2026-07-30T20:56:08.251Z. Its registry update date was 2019-02-15, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct00765999-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2019-02-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00765999-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct00765999-linaclotide-v1
- Content SHA-256: `9a6305699889d5509aebc477f0d3acc43af3119e7b2fd9228148f48d8271e26a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00765999 ([`ctg-observation-nct00765999-2019-02-15-9e5435c6c997`](#source-ctg-observation-nct00765999-2019-02-15-9e5435c6c997))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00765999 at 2026-07-30T20:56:08.251Z. Its registry update date was 2019-02-15, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct00765999-2019-02-15-9e5435c6c997`](#source-ctg-observation-nct00765999-2019-02-15-9e5435c6c997))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00765999 at 2026-07-30T20:56:08.251Z. Its registry update date was 2019-02-15, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct00765999-2019-02-15-9e5435c6c997`](#source-ctg-observation-nct00765999-2019-02-15-9e5435c6c997))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00765999-2019-02-15-9e5435c6c997`](#source-ctg-observation-nct00765999-2019-02-15-9e5435c6c997))

### Sources

<a id="source-ctg-observation-nct00765999-2019-02-15-9e5435c6c997"></a>
- **ClinicalTrials.gov record NCT00765999 · retained source version 2019-02-15:9e5435c6c997a423df2ccd718b40cc06cd607ddeed80abf2d1727abdd096ca4c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00765999) (`ctg-observation-nct00765999-2019-02-15-9e5435c6c997`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00765999." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct00765999-linaclotide-v1 SHA-256: 9a6305699889d5509aebc477f0d3acc43af3119e7b2fd9228148f48d8271e26a.

---

<a id="clinicaltrials-gov-nct01950403-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT01950403

> PeptideScanner retained ClinicalTrials.gov record NCT01950403 at 2026-07-30T18:37:14.701Z. Its registry update date was 2024-12-09, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct01950403-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-12-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01950403-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct01950403-linaclotide-v1
- Content SHA-256: `ab07074270145a3ffac76d9778624780627ac2054b1ab18d6803891df5e477f9`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01950403 ([`ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30`](#source-ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01950403 at 2026-07-30T18:37:14.701Z. Its registry update date was 2024-12-09, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30`](#source-ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01950403 at 2026-07-30T18:37:14.701Z. Its registry update date was 2024-12-09, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30`](#source-ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30`](#source-ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30))

### Sources

<a id="source-ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30"></a>
- **ClinicalTrials.gov record NCT01950403 · retained source version 2024-12-09:eaf4dfd7bb30417b53a12800bdca4ef5524c46c6146b63ad514729dcad2b2740** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01950403) (`ctg-observation-nct01950403-2024-12-09-eaf4dfd7bb30`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01950403." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct01950403-linaclotide-v1 SHA-256: ab07074270145a3ffac76d9778624780627ac2054b1ab18d6803891df5e477f9.

---

<a id="clinicaltrials-gov-nct02078323-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT02078323

> PeptideScanner retained ClinicalTrials.gov record NCT02078323 at 2026-07-30T21:10:02.997Z. Its registry update date was 2018-07-23, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct02078323-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-07-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02078323-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct02078323-linaclotide-v1
- Content SHA-256: `e88c2b5e696d7218e8312c5ee9e965bb8a60bae13758b319f88abdf701aa0247`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02078323 ([`ctg-observation-nct02078323-2018-07-23-380581a5140f`](#source-ctg-observation-nct02078323-2018-07-23-380581a5140f))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02078323 at 2026-07-30T21:10:02.997Z. Its registry update date was 2018-07-23, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02078323-2018-07-23-380581a5140f`](#source-ctg-observation-nct02078323-2018-07-23-380581a5140f))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02078323 at 2026-07-30T21:10:02.997Z. Its registry update date was 2018-07-23, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02078323-2018-07-23-380581a5140f`](#source-ctg-observation-nct02078323-2018-07-23-380581a5140f))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02078323-2018-07-23-380581a5140f`](#source-ctg-observation-nct02078323-2018-07-23-380581a5140f))

### Sources

<a id="source-ctg-observation-nct02078323-2018-07-23-380581a5140f"></a>
- **ClinicalTrials.gov record NCT02078323 · retained source version 2018-07-23:380581a5140ffb4df8210809e3207600a21d10f32609800291b611bb95565abc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02078323) (`ctg-observation-nct02078323-2018-07-23-380581a5140f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02078323." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct02078323-linaclotide-v1 SHA-256: e88c2b5e696d7218e8312c5ee9e965bb8a60bae13758b319f88abdf701aa0247.

---

<a id="clinicaltrials-gov-nct02220348-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT02220348

> PeptideScanner retained ClinicalTrials.gov record NCT02220348 at 2026-07-30T20:18:37.979Z. Its registry update date was 2020-12-19, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct02220348-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2020-12-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02220348-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct02220348-linaclotide-v1
- Content SHA-256: `f13b865cad4dfb8177d70de105f3efdbe81ff9797c044eea759a60ceb9683621`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02220348 ([`ctg-observation-nct02220348-2020-12-19-e328b7e45096`](#source-ctg-observation-nct02220348-2020-12-19-e328b7e45096))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02220348 at 2026-07-30T20:18:37.979Z. Its registry update date was 2020-12-19, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02220348-2020-12-19-e328b7e45096`](#source-ctg-observation-nct02220348-2020-12-19-e328b7e45096))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02220348 at 2026-07-30T20:18:37.979Z. Its registry update date was 2020-12-19, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02220348-2020-12-19-e328b7e45096`](#source-ctg-observation-nct02220348-2020-12-19-e328b7e45096))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02220348-2020-12-19-e328b7e45096`](#source-ctg-observation-nct02220348-2020-12-19-e328b7e45096))

### Sources

<a id="source-ctg-observation-nct02220348-2020-12-19-e328b7e45096"></a>
- **ClinicalTrials.gov record NCT02220348 · retained source version 2020-12-19:e328b7e450964aafc1ddcad69dac79749ee33ab970430682872cbfe7c6b439f3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02220348) (`ctg-observation-nct02220348-2020-12-19-e328b7e45096`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02220348." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct02220348-linaclotide-v1 SHA-256: f13b865cad4dfb8177d70de105f3efdbe81ff9797c044eea759a60ceb9683621.

---

<a id="clinicaltrials-gov-nct02291679-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT02291679

> PeptideScanner retained ClinicalTrials.gov record NCT02291679 at 2026-07-30T21:24:24.231Z. Its registry update date was 2017-06-15, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct02291679-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-06-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02291679-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct02291679-linaclotide-v1
- Content SHA-256: `27f2d4dae22e9e775bc97f48bc03bed6dd3bd2a1488064555e3c122a670a4729`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02291679 ([`ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153`](#source-ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02291679 at 2026-07-30T21:24:24.231Z. Its registry update date was 2017-06-15, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153`](#source-ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02291679 at 2026-07-30T21:24:24.231Z. Its registry update date was 2017-06-15, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153`](#source-ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153`](#source-ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153))

### Sources

<a id="source-ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153"></a>
- **ClinicalTrials.gov record NCT02291679 · retained source version 2017-06-15:cf9a7ba8e1538b05bbbd9499cc667eca5a4e8a078e5c470331b7819b5579b589** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02291679) (`ctg-observation-nct02291679-2017-06-15-cf9a7ba8e153`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02291679." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct02291679-linaclotide-v1 SHA-256: 27f2d4dae22e9e775bc97f48bc03bed6dd3bd2a1488064555e3c122a670a4729.

---

<a id="clinicaltrials-gov-nct02559206-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT02559206

> PeptideScanner retained ClinicalTrials.gov record NCT02559206 at 2026-07-30T20:29:13.579Z. Its registry update date was 2020-04-24, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct02559206-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2020-04-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02559206-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct02559206-linaclotide-v1
- Content SHA-256: `0192cf34a82be97a98644ce2e9d2410f5675bb797b2283de852cd2c9bf40ea72`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02559206 ([`ctg-observation-nct02559206-2020-04-24-5db39d62c302`](#source-ctg-observation-nct02559206-2020-04-24-5db39d62c302))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02559206 at 2026-07-30T20:29:13.579Z. Its registry update date was 2020-04-24, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02559206-2020-04-24-5db39d62c302`](#source-ctg-observation-nct02559206-2020-04-24-5db39d62c302))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02559206 at 2026-07-30T20:29:13.579Z. Its registry update date was 2020-04-24, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02559206-2020-04-24-5db39d62c302`](#source-ctg-observation-nct02559206-2020-04-24-5db39d62c302))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02559206-2020-04-24-5db39d62c302`](#source-ctg-observation-nct02559206-2020-04-24-5db39d62c302))

### Sources

<a id="source-ctg-observation-nct02559206-2020-04-24-5db39d62c302"></a>
- **ClinicalTrials.gov record NCT02559206 · retained source version 2020-04-24:5db39d62c30216da474d709d107253525c3813edbca2b746a77f876201b195da** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02559206) (`ctg-observation-nct02559206-2020-04-24-5db39d62c302`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02559206." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct02559206-linaclotide-v1 SHA-256: 0192cf34a82be97a98644ce2e9d2410f5675bb797b2283de852cd2c9bf40ea72.

---

<a id="clinicaltrials-gov-nct03119584-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT03119584

> PeptideScanner retained ClinicalTrials.gov record NCT03119584 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-03, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct03119584-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03119584-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct03119584-linaclotide-v1
- Content SHA-256: `88b16ef1abbf2a88b6a31082bd5baf3e3db3aec1d36f0990ae3402de77ac3748`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03119584 ([`ctg-observation-nct03119584-2026-04-03-89a9433c5770`](#source-ctg-observation-nct03119584-2026-04-03-89a9433c5770))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03119584 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-03, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03119584-2026-04-03-89a9433c5770`](#source-ctg-observation-nct03119584-2026-04-03-89a9433c5770))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03119584 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-03, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03119584-2026-04-03-89a9433c5770`](#source-ctg-observation-nct03119584-2026-04-03-89a9433c5770))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03119584-2026-04-03-89a9433c5770`](#source-ctg-observation-nct03119584-2026-04-03-89a9433c5770))

### Sources

<a id="source-ctg-observation-nct03119584-2026-04-03-89a9433c5770"></a>
- **ClinicalTrials.gov record NCT03119584 · retained source version 2026-04-03:89a9433c57700be79ae011b37f11ab4c4ce38313c24b0a55f4eb3eaca21ee5ee** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03119584) (`ctg-observation-nct03119584-2026-04-03-89a9433c5770`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03119584." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct03119584-linaclotide-v1 SHA-256: 88b16ef1abbf2a88b6a31082bd5baf3e3db3aec1d36f0990ae3402de77ac3748.

---

<a id="clinicaltrials-gov-nct03471728-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT03471728

> PeptideScanner retained ClinicalTrials.gov record NCT03471728 at 2026-07-30T18:39:33.779Z. Its registry update date was 2024-10-18, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct03471728-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-10-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03471728-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct03471728-linaclotide-v1
- Content SHA-256: `8f7b7454c4b93a246de89c2d981a069851bc55f517ae0577cdc3ea98b20e4ecf`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03471728 ([`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`](#source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03471728 at 2026-07-30T18:39:33.779Z. Its registry update date was 2024-10-18, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`](#source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03471728 at 2026-07-30T18:39:33.779Z. Its registry update date was 2024-10-18, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`](#source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`](#source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3))

### Sources

<a id="source-ctg-observation-nct03471728-2024-10-18-972598ce2ea3"></a>
- **ClinicalTrials.gov record NCT03471728 · retained source version 2024-10-18:972598ce2ea3019692aeac8eab2d77443fe2c07b400759d221ff0ca477f42043** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03471728) (`ctg-observation-nct03471728-2024-10-18-972598ce2ea3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03471728." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct03471728-linaclotide-v1 SHA-256: 8f7b7454c4b93a246de89c2d981a069851bc55f517ae0577cdc3ea98b20e4ecf.

---

<a id="clinicaltrials-gov-nct03573908-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT03573908

> PeptideScanner retained ClinicalTrials.gov record NCT03573908 at 2026-07-30T20:18:37.978Z. Its registry update date was 2020-12-01, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct03573908-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2020-12-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03573908-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct03573908-linaclotide-v1
- Content SHA-256: `9cce527f603a448d69b129d2c49ddb3665c74a0396c4dc25f96959e058338385`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03573908 ([`ctg-observation-nct03573908-2020-12-01-db76bce1d017`](#source-ctg-observation-nct03573908-2020-12-01-db76bce1d017))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03573908 at 2026-07-30T20:18:37.978Z. Its registry update date was 2020-12-01, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03573908-2020-12-01-db76bce1d017`](#source-ctg-observation-nct03573908-2020-12-01-db76bce1d017))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03573908 at 2026-07-30T20:18:37.978Z. Its registry update date was 2020-12-01, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03573908-2020-12-01-db76bce1d017`](#source-ctg-observation-nct03573908-2020-12-01-db76bce1d017))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03573908-2020-12-01-db76bce1d017`](#source-ctg-observation-nct03573908-2020-12-01-db76bce1d017))

### Sources

<a id="source-ctg-observation-nct03573908-2020-12-01-db76bce1d017"></a>
- **ClinicalTrials.gov record NCT03573908 · retained source version 2020-12-01:db76bce1d0179b7a963da50d21664ff0ad557233cba2df7f2daa818999c4a75f** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03573908) (`ctg-observation-nct03573908-2020-12-01-db76bce1d017`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03573908." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct03573908-linaclotide-v1 SHA-256: 9cce527f603a448d69b129d2c49ddb3665c74a0396c4dc25f96959e058338385.

---

<a id="clinicaltrials-gov-nct03796884-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT03796884

> PeptideScanner retained ClinicalTrials.gov record NCT03796884 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct03796884-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-22
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03796884-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct03796884-linaclotide-v1
- Content SHA-256: `b8a89f205e75c73953326c42042b6173c2a47b2807f53d785b3fb602fd506e37`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03796884 ([`ctg-observation-nct03796884-2026-07-22-fb310d5da688`](#source-ctg-observation-nct03796884-2026-07-22-fb310d5da688))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03796884 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03796884-2026-07-22-fb310d5da688`](#source-ctg-observation-nct03796884-2026-07-22-fb310d5da688))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03796884 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03796884-2026-07-22-fb310d5da688`](#source-ctg-observation-nct03796884-2026-07-22-fb310d5da688))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03796884-2026-07-22-fb310d5da688`](#source-ctg-observation-nct03796884-2026-07-22-fb310d5da688))

### Sources

<a id="source-ctg-observation-nct03796884-2026-07-22-fb310d5da688"></a>
- **ClinicalTrials.gov record NCT03796884 · retained source version 2026-07-22:fb310d5da68866e030991ed3c74ab6d9270e93f4581d0a02cc6a7a6bc9b51825** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03796884) (`ctg-observation-nct03796884-2026-07-22-fb310d5da688`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03796884." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct03796884-linaclotide-v1 SHA-256: b8a89f205e75c73953326c42042b6173c2a47b2807f53d785b3fb602fd506e37.

---

<a id="clinicaltrials-gov-nct05652205-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT05652205

> PeptideScanner retained ClinicalTrials.gov record NCT05652205 at 2026-07-30T16:19:36.913Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct05652205-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05652205-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct05652205-linaclotide-v1
- Content SHA-256: `30776001fbad4dc6e1369479a7c1bcb3c66b1cfd039f0b71de159de427cfff42`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05652205 ([`ctg-observation-nct05652205-2026-05-14-04a260f10036`](#source-ctg-observation-nct05652205-2026-05-14-04a260f10036))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05652205 at 2026-07-30T16:19:36.913Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct05652205-2026-05-14-04a260f10036`](#source-ctg-observation-nct05652205-2026-05-14-04a260f10036))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05652205 at 2026-07-30T16:19:36.913Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct05652205-2026-05-14-04a260f10036`](#source-ctg-observation-nct05652205-2026-05-14-04a260f10036))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05652205-2026-05-14-04a260f10036`](#source-ctg-observation-nct05652205-2026-05-14-04a260f10036))

### Sources

<a id="source-ctg-observation-nct05652205-2026-05-14-04a260f10036"></a>
- **ClinicalTrials.gov record NCT05652205 · retained source version 2026-05-14:04a260f10036f3f92da723ec0f0366b66df5f077c1374a023d6a98ee89f4d440** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05652205) (`ctg-observation-nct05652205-2026-05-14-04a260f10036`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05652205." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct05652205-linaclotide-v1 SHA-256: 30776001fbad4dc6e1369479a7c1bcb3c66b1cfd039f0b71de159de427cfff42.

---

<a id="clinicaltrials-gov-nct05760313-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT05760313

> PeptideScanner retained ClinicalTrials.gov record NCT05760313 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct05760313-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-01-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05760313-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct05760313-linaclotide-v1
- Content SHA-256: `2522e844c8a2fe48711d9d157b43a6823a72b2c2bf9c2d6114b3f53fd5b5e5de`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05760313 ([`ctg-observation-nct05760313-2026-01-06-8b520537947a`](#source-ctg-observation-nct05760313-2026-01-06-8b520537947a))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05760313 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct05760313-2026-01-06-8b520537947a`](#source-ctg-observation-nct05760313-2026-01-06-8b520537947a))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05760313 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct05760313-2026-01-06-8b520537947a`](#source-ctg-observation-nct05760313-2026-01-06-8b520537947a))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05760313-2026-01-06-8b520537947a`](#source-ctg-observation-nct05760313-2026-01-06-8b520537947a))

### Sources

<a id="source-ctg-observation-nct05760313-2026-01-06-8b520537947a"></a>
- **ClinicalTrials.gov record NCT05760313 · retained source version 2026-01-06:8b520537947a0ad0aca2539c9ab85590e9975a67e4775c97c170a1d284b8abd1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05760313) (`ctg-observation-nct05760313-2026-01-06-8b520537947a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05760313." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct05760313-linaclotide-v1 SHA-256: 2522e844c8a2fe48711d9d157b43a6823a72b2c2bf9c2d6114b3f53fd5b5e5de.

---

<a id="clinicaltrials-gov-nct05796388-linaclotide-v1"></a>

## ClinicalTrials.gov record NCT05796388

> PeptideScanner retained ClinicalTrials.gov record NCT05796388 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct05796388-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-29
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05796388-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct05796388-linaclotide-v1
- Content SHA-256: `2aace6f1bcfcca3c6418c1f18d81493b0ba849d67d39686e7bd924ce2fb0bf9b`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05796388 ([`ctg-observation-nct05796388-2026-07-29-a8d8aed684b1`](#source-ctg-observation-nct05796388-2026-07-29-a8d8aed684b1))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05796388 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct05796388-2026-07-29-a8d8aed684b1`](#source-ctg-observation-nct05796388-2026-07-29-a8d8aed684b1))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05796388 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct05796388-2026-07-29-a8d8aed684b1`](#source-ctg-observation-nct05796388-2026-07-29-a8d8aed684b1))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05796388-2026-07-29-a8d8aed684b1`](#source-ctg-observation-nct05796388-2026-07-29-a8d8aed684b1))

### Sources

<a id="source-ctg-observation-nct05796388-2026-07-29-a8d8aed684b1"></a>
- **ClinicalTrials.gov record NCT05796388 · retained source version 2026-07-29:a8d8aed684b175b636659d1c01b087bc41f0e69659580e35e1fb581df3557cf1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05796388) (`ctg-observation-nct05796388-2026-07-29-a8d8aed684b1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05796388." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#clinicaltrials-gov-nct05796388-linaclotide-v1 SHA-256: 2aace6f1bcfcca3c6418c1f18d81493b0ba849d67d39686e7bd924ce2fb0bf9b.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-v1"></a>

## Linaclotide DailyMed SPL version 10

> DailyMed lists Structured Product Labeling version 10 for the reviewed Linaclotide label family with a published date of 2016-04-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10:v1`
- Evidence domain: Regulatory
- Date in source: 2016-04-18
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-v1
- Content SHA-256: `3cc271377413c861504af3bd52fd6d9d6e4120350b34dc29c373971b1765c084`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 10 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history))

#### Summary

DailyMed lists Structured Product Labeling version 10 for the reviewed Linaclotide label family with a published date of 2016-04-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 10 for the reviewed Linaclotide label family with a published date of 2016-04-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 10 · published 2016-04-18 · retained ZIP SHA-256 3ee6d7001d49919a8f3abe00ec8a3f4c4fe4e2de7014039cf83c6090764b079b** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=10) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 10." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v10-v1 SHA-256: 3cc271377413c861504af3bd52fd6d9d6e4120350b34dc29c373971b1765c084.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-v1"></a>

## Linaclotide DailyMed SPL version 11

> DailyMed lists Structured Product Labeling version 11 for the reviewed Linaclotide label family with a published date of 2016-09-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11:v1`
- Evidence domain: Regulatory
- Date in source: 2016-09-20
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-v1
- Content SHA-256: `0a3bf34f7d53585925d3fe2312169830c374dcf88fec96e48ca0ef594ba14d35`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 11 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history))

#### Summary

DailyMed lists Structured Product Labeling version 11 for the reviewed Linaclotide label family with a published date of 2016-09-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 11 for the reviewed Linaclotide label family with a published date of 2016-09-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 11 · published 2016-09-20 · retained ZIP SHA-256 1a7e565213743959c422ae22b7bf7fc76c01c41acae332d4f0a5b8c6556db39c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=11) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 11." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v11-v1 SHA-256: 0a3bf34f7d53585925d3fe2312169830c374dcf88fec96e48ca0ef594ba14d35.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-v1"></a>

## Linaclotide DailyMed SPL version 12

> DailyMed lists Structured Product Labeling version 12 for the reviewed Linaclotide label family with a published date of 2016-11-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12:v1`
- Evidence domain: Regulatory
- Date in source: 2016-11-03
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-v1
- Content SHA-256: `4ceadd957d3671612d4f622850b96f9cbc49ccae23f819ac42270523475527d7`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 12 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history))

#### Summary

DailyMed lists Structured Product Labeling version 12 for the reviewed Linaclotide label family with a published date of 2016-11-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 12 for the reviewed Linaclotide label family with a published date of 2016-11-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 12 · published 2016-11-03 · retained ZIP SHA-256 d03c5122a82101cd2722135788e8bf3961e38d0ee3c60f0431b6a09c55ed2994** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=12) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 12." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v12-v1 SHA-256: 4ceadd957d3671612d4f622850b96f9cbc49ccae23f819ac42270523475527d7.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-v1"></a>

## Linaclotide DailyMed SPL version 13

> DailyMed lists Structured Product Labeling version 13 for the reviewed Linaclotide label family with a published date of 2017-02-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13:v1`
- Evidence domain: Regulatory
- Date in source: 2017-02-15
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-v1
- Content SHA-256: `e52e8aff151e96aafb6edf30e0c4c73cc34119415758bf8e63cced30a4c8ccb4`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 13 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history))

#### Summary

DailyMed lists Structured Product Labeling version 13 for the reviewed Linaclotide label family with a published date of 2017-02-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 13 for the reviewed Linaclotide label family with a published date of 2017-02-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 13 · published 2017-02-15 · retained ZIP SHA-256 1b558838e70c37251f0056162788f6597c30dc6a3b34407d76318526ad2bb8d0** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=13) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 13." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v13-v1 SHA-256: e52e8aff151e96aafb6edf30e0c4c73cc34119415758bf8e63cced30a4c8ccb4.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-v1"></a>

## Linaclotide DailyMed SPL version 14

> DailyMed lists Structured Product Labeling version 14 for the reviewed Linaclotide label family with a published date of 2017-06-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14:v1`
- Evidence domain: Regulatory
- Date in source: 2017-06-08
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-v1
- Content SHA-256: `941ac4541a37ce0cf385f11c605bb55344124fae083dc1f16d0c202217c3c2a1`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 14 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history))

#### Summary

DailyMed lists Structured Product Labeling version 14 for the reviewed Linaclotide label family with a published date of 2017-06-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 14 for the reviewed Linaclotide label family with a published date of 2017-06-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 14 · published 2017-06-08 · retained ZIP SHA-256 60c3849160f11f1677f2dfbec4358d05d6c1535f5c4d5cb40e2c618cd4ac9852** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=14) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 14." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v14-v1 SHA-256: 941ac4541a37ce0cf385f11c605bb55344124fae083dc1f16d0c202217c3c2a1.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-v1"></a>

## Linaclotide DailyMed SPL version 15

> DailyMed lists Structured Product Labeling version 15 for the reviewed Linaclotide label family with a published date of 2017-06-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15:v1`
- Evidence domain: Regulatory
- Date in source: 2017-06-26
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-v1
- Content SHA-256: `ec1215dda885c5635d8001c016144279d45c4dc2b9d03c181227338081ff9d5d`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 15 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history))

#### Summary

DailyMed lists Structured Product Labeling version 15 for the reviewed Linaclotide label family with a published date of 2017-06-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 15 for the reviewed Linaclotide label family with a published date of 2017-06-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 15 · published 2017-06-26 · retained ZIP SHA-256 379c4d8b18fc205458bc7c42551d80e0b24b8a0f4bc44087a2ac2b9283dd726f** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=15) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 15." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v15-v1 SHA-256: ec1215dda885c5635d8001c016144279d45c4dc2b9d03c181227338081ff9d5d.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-v1"></a>

## Linaclotide DailyMed SPL version 16

> DailyMed lists Structured Product Labeling version 16 for the reviewed Linaclotide label family with a published date of 2017-07-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16:v1`
- Evidence domain: Regulatory
- Date in source: 2017-07-03
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-v1
- Content SHA-256: `bb02f330a2f86ce596bcc4118c30610a4425df9bd8ab73a7602a59fa47d04917`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 16 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history))

#### Summary

DailyMed lists Structured Product Labeling version 16 for the reviewed Linaclotide label family with a published date of 2017-07-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 16 for the reviewed Linaclotide label family with a published date of 2017-07-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 16 · published 2017-07-03 · retained ZIP SHA-256 da8ff8e5a69e8edd1e7dc2784e39d5a52d8804365a370123e041988eba40e493** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=16) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 16." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v16-v1 SHA-256: bb02f330a2f86ce596bcc4118c30610a4425df9bd8ab73a7602a59fa47d04917.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-v1"></a>

## Linaclotide DailyMed SPL version 17

> DailyMed lists Structured Product Labeling version 17 for the reviewed Linaclotide label family with a published date of 2017-11-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17:v1`
- Evidence domain: Regulatory
- Date in source: 2017-11-02
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-v1
- Content SHA-256: `ff38874174a4d484b147b44f86048409181189e9459f9e6f4b6b1119de989584`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 17 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history))

#### Summary

DailyMed lists Structured Product Labeling version 17 for the reviewed Linaclotide label family with a published date of 2017-11-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 17 for the reviewed Linaclotide label family with a published date of 2017-11-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 17 · published 2017-11-02 · retained ZIP SHA-256 3d1b9c6c3a27cd1b0f70a775d6e2b4e5045f2d34fa0f59ef31bc7e946a71abfe** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=17) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 17." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v17-v1 SHA-256: ff38874174a4d484b147b44f86048409181189e9459f9e6f4b6b1119de989584.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-v1"></a>

## Linaclotide DailyMed SPL version 18

> DailyMed lists Structured Product Labeling version 18 for the reviewed Linaclotide label family with a published date of 2018-12-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18:v1`
- Evidence domain: Regulatory
- Date in source: 2018-12-07
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-v1
- Content SHA-256: `eaaa080dfd542643cdbe51bfd7ee071da59de5f3188ea6cd5818b5c132d0e1e1`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 18 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history))

#### Summary

DailyMed lists Structured Product Labeling version 18 for the reviewed Linaclotide label family with a published date of 2018-12-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 18 for the reviewed Linaclotide label family with a published date of 2018-12-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 18 · published 2018-12-07 · retained ZIP SHA-256 a5a929c12a87825552c988b96089e1522b4d2316adf1785722a4372368283ce3** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=18) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 18." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v18-v1 SHA-256: eaaa080dfd542643cdbe51bfd7ee071da59de5f3188ea6cd5818b5c132d0e1e1.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-v1"></a>

## Linaclotide DailyMed SPL version 23

> DailyMed lists Structured Product Labeling version 23 for the reviewed Linaclotide label family with a published date of 2020-10-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23:v1`
- Evidence domain: Regulatory
- Date in source: 2020-10-01
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-v1
- Content SHA-256: `b2d21d5e1772175f9099bf1c74c1de16d4b57e083727ca420caee5ed68715e90`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 23 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history))

#### Summary

DailyMed lists Structured Product Labeling version 23 for the reviewed Linaclotide label family with a published date of 2020-10-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 23 for the reviewed Linaclotide label family with a published date of 2020-10-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 23 · published 2020-10-01 · retained ZIP SHA-256 dab89e3534ccd1510470a3abb91ff917c2e4d90f471ab8ab1c2d988a4fdbc6a2** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=23) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 23." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v23-v1 SHA-256: b2d21d5e1772175f9099bf1c74c1de16d4b57e083727ca420caee5ed68715e90.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-v1"></a>

## Linaclotide DailyMed SPL version 26

> DailyMed lists Structured Product Labeling version 26 for the reviewed Linaclotide label family with a published date of 2021-04-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26:v1`
- Evidence domain: Regulatory
- Date in source: 2021-04-16
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-v1
- Content SHA-256: `8c6fbc7cf2b8ba6fa4dab58258df5234c9ea4b795b2a0f6f5c8e41411b47d875`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 26 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history))

#### Summary

DailyMed lists Structured Product Labeling version 26 for the reviewed Linaclotide label family with a published date of 2021-04-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 26 for the reviewed Linaclotide label family with a published date of 2021-04-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 26 · published 2021-04-16 · retained ZIP SHA-256 a4794ceb0f54af1b6f723cd829eccf90811fc6c9b43a8eaa5c9ddd502a12561e** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=26) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 26." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v26-v1 SHA-256: 8c6fbc7cf2b8ba6fa4dab58258df5234c9ea4b795b2a0f6f5c8e41411b47d875.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-v1"></a>

## Linaclotide DailyMed SPL version 27

> DailyMed lists Structured Product Labeling version 27 for the reviewed Linaclotide label family with a published date of 2021-04-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27:v1`
- Evidence domain: Regulatory
- Date in source: 2021-04-20
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-v1
- Content SHA-256: `db545d059853e1cd2c6ab2d029e2b1a2f01023c0974e3d485496e18edfe1ebba`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 27 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history))

#### Summary

DailyMed lists Structured Product Labeling version 27 for the reviewed Linaclotide label family with a published date of 2021-04-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 27 for the reviewed Linaclotide label family with a published date of 2021-04-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 27 · published 2021-04-20 · retained ZIP SHA-256 1c902d33a51805be67a6b5e14507f512354f632874d8984a8a8c3494ead1a11c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=27) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 27." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v27-v1 SHA-256: db545d059853e1cd2c6ab2d029e2b1a2f01023c0974e3d485496e18edfe1ebba.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-v1"></a>

## Linaclotide DailyMed SPL version 28

> DailyMed lists Structured Product Labeling version 28 for the reviewed Linaclotide label family with a published date of 2021-09-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28:v1`
- Evidence domain: Regulatory
- Date in source: 2021-09-08
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-v1
- Content SHA-256: `d2c1075e4e6b1472f9b42ad02a4a50aa9e6429f48b7aa7cc63d55c04fba4a9cf`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 28 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history))

#### Summary

DailyMed lists Structured Product Labeling version 28 for the reviewed Linaclotide label family with a published date of 2021-09-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 28 for the reviewed Linaclotide label family with a published date of 2021-09-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 28 · published 2021-09-08 · retained ZIP SHA-256 af1771ae83a83ab3db2634054bcad729cbcc97feadced0c3980941236f7b50d5** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=28) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 28." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v28-v1 SHA-256: d2c1075e4e6b1472f9b42ad02a4a50aa9e6429f48b7aa7cc63d55c04fba4a9cf.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-v1"></a>

## Linaclotide DailyMed SPL version 2

> DailyMed lists Structured Product Labeling version 2 for the reviewed Linaclotide label family with a published date of 2012-09-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2:v1`
- Evidence domain: Regulatory
- Date in source: 2012-09-11
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-v1
- Content SHA-256: `31df900211ea3c846c1699b9194a997387cfbb6633958a06191818c2289d2716`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 2 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history))

#### Summary

DailyMed lists Structured Product Labeling version 2 for the reviewed Linaclotide label family with a published date of 2012-09-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 2 for the reviewed Linaclotide label family with a published date of 2012-09-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 2 · published 2012-09-11 · retained ZIP SHA-256 4ab55c165d5f772625954e40590c7703700ee33fc9f326450e2ace9a634e6dbb** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=2) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 2." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v2-v1 SHA-256: 31df900211ea3c846c1699b9194a997387cfbb6633958a06191818c2289d2716.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-v1"></a>

## Linaclotide DailyMed SPL version 30

> DailyMed lists Structured Product Labeling version 30 for the reviewed Linaclotide label family with a published date of 2022-12-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30:v1`
- Evidence domain: Regulatory
- Date in source: 2022-12-06
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-v1
- Content SHA-256: `d70703f7647ecf846dff9927b112c0f6625877df5b8555a6f2eabe6ebee326c3`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 30 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history))

#### Summary

DailyMed lists Structured Product Labeling version 30 for the reviewed Linaclotide label family with a published date of 2022-12-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 30 for the reviewed Linaclotide label family with a published date of 2022-12-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 30 · published 2022-12-06 · retained ZIP SHA-256 bfff13e8ada17a6819a93c10bf6cb6cd43ea2edeb1f9cc559d944819fd2ea37e** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=30) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 30." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v30-v1 SHA-256: d70703f7647ecf846dff9927b112c0f6625877df5b8555a6f2eabe6ebee326c3.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-v1"></a>

## Linaclotide DailyMed SPL version 31

> DailyMed lists Structured Product Labeling version 31 for the reviewed Linaclotide label family with a published date of 2023-05-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31:v1`
- Evidence domain: Regulatory
- Date in source: 2023-05-05
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-v1
- Content SHA-256: `3551ff5e0a5161f633fe9b213abeb63e44c3f2764fb9fc681cbceadf003beb2e`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 31 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history))

#### Summary

DailyMed lists Structured Product Labeling version 31 for the reviewed Linaclotide label family with a published date of 2023-05-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 31 for the reviewed Linaclotide label family with a published date of 2023-05-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 31 · published 2023-05-05 · retained ZIP SHA-256 4e4729de1ea381e22900059a6457bccce6ddd07a538d7d11a78ebdc6a538a8b3** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=31) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 31." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v31-v1 SHA-256: 3551ff5e0a5161f633fe9b213abeb63e44c3f2764fb9fc681cbceadf003beb2e.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-v1"></a>

## Linaclotide DailyMed SPL version 32

> DailyMed lists Structured Product Labeling version 32 for the reviewed Linaclotide label family with a published date of 2023-06-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32:v1`
- Evidence domain: Regulatory
- Date in source: 2023-06-21
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-v1
- Content SHA-256: `9c7edeebe1352a98273b57684d64a88d0bc737e2bcc7098265a6b7cd768376b9`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 32 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history))

#### Summary

DailyMed lists Structured Product Labeling version 32 for the reviewed Linaclotide label family with a published date of 2023-06-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 32 for the reviewed Linaclotide label family with a published date of 2023-06-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 32 · published 2023-06-21 · retained ZIP SHA-256 dc7f001ae30ad8bcef158fbac9c11649295bac356bfdef4125270b9716f95a4c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=32) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 32." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v32-v1 SHA-256: 9c7edeebe1352a98273b57684d64a88d0bc737e2bcc7098265a6b7cd768376b9.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-v1"></a>

## Linaclotide DailyMed SPL version 33

> DailyMed lists Structured Product Labeling version 33 for the reviewed Linaclotide label family with a published date of 2023-09-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33:v1`
- Evidence domain: Regulatory
- Date in source: 2023-09-21
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-v1
- Content SHA-256: `f74dc487bb3465bcd830661f70334a88a26d15ae247525f1fc0591a4cd5fc01e`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 33 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history))

#### Summary

DailyMed lists Structured Product Labeling version 33 for the reviewed Linaclotide label family with a published date of 2023-09-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 33 for the reviewed Linaclotide label family with a published date of 2023-09-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 33 · published 2023-09-21 · retained ZIP SHA-256 43fb2fc11c3ac2a4e3fd52ada7f842cd0890a1cbbdd29411aaff34542ca80776** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=33) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 33." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v33-v1 SHA-256: f74dc487bb3465bcd830661f70334a88a26d15ae247525f1fc0591a4cd5fc01e.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-v1"></a>

## Linaclotide DailyMed SPL version 34

> DailyMed lists Structured Product Labeling version 34 for the reviewed Linaclotide label family with a published date of 2024-07-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34:v1`
- Evidence domain: Regulatory
- Date in source: 2024-07-11
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-v1
- Content SHA-256: `5c1e5ad295f8bedd4d1ef64d33b412435487be8606fca1cd59547b4e8f7ea6db`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 34 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history))

#### Summary

DailyMed lists Structured Product Labeling version 34 for the reviewed Linaclotide label family with a published date of 2024-07-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 34 for the reviewed Linaclotide label family with a published date of 2024-07-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 34 · published 2024-07-11 · retained ZIP SHA-256 c7453e08068fdd5c8e0607d89fe2d13feff065f60d58e8c0f6ba688317d6607c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=34) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 34." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v34-v1 SHA-256: 5c1e5ad295f8bedd4d1ef64d33b412435487be8606fca1cd59547b4e8f7ea6db.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-v1"></a>

## Linaclotide DailyMed SPL version 36

> DailyMed lists Structured Product Labeling version 36 for the reviewed Linaclotide label family with a published date of 2025-11-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36:v1`
- Evidence domain: Regulatory
- Date in source: 2025-11-17
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-v1
- Content SHA-256: `2de36c55adfca6b47820f0221f95a2f0ca98df7c2b650017d3867cd108efd36b`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 36 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history))

#### Summary

DailyMed lists Structured Product Labeling version 36 for the reviewed Linaclotide label family with a published date of 2025-11-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 36 for the reviewed Linaclotide label family with a published date of 2025-11-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 36 · published 2025-11-17 · retained ZIP SHA-256 65eb80d6a219a29ba83dea92a8d47b79515279c3aaca6742463c4c6789dc51c8** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=36) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 36." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v36-v1 SHA-256: 2de36c55adfca6b47820f0221f95a2f0ca98df7c2b650017d3867cd108efd36b.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-v1"></a>

## Linaclotide DailyMed SPL version 38

> DailyMed lists Structured Product Labeling version 38 for the reviewed Linaclotide label family with a published date of 2026-01-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38:v1`
- Evidence domain: Regulatory
- Date in source: 2026-01-16
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-v1
- Content SHA-256: `a9731b900aa88b2b8455f787dbcd27b4956e3f8fcd6d1ffe34e465ada48ab0ce`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 38 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history))

#### Summary

DailyMed lists Structured Product Labeling version 38 for the reviewed Linaclotide label family with a published date of 2026-01-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 38 for the reviewed Linaclotide label family with a published date of 2026-01-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 38 · published 2026-01-16 · retained ZIP SHA-256 d34462beabf136008f4dc25357162b905b05a5b39db3fa9ac29afb7c231abe7c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=38) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 38." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v38-v1 SHA-256: a9731b900aa88b2b8455f787dbcd27b4956e3f8fcd6d1ffe34e465ada48ab0ce.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-v1"></a>

## Linaclotide DailyMed SPL version 39

> DailyMed lists Structured Product Labeling version 39 for the reviewed Linaclotide label family with a published date of 2026-06-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39:v1`
- Evidence domain: Regulatory
- Date in source: 2026-06-01
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-v1
- Content SHA-256: `7b7269b6b93124fe68ed7eee6873dd33bd9f4950ca9d0ac6c6125a44cd6fb077`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 39 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history))

#### Summary

DailyMed lists Structured Product Labeling version 39 for the reviewed Linaclotide label family with a published date of 2026-06-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 39 for the reviewed Linaclotide label family with a published date of 2026-06-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 39 · published 2026-06-01 · retained ZIP SHA-256 77c54fc2bf053002e1fd77970d745d4088919827b5a4a74d5d139cf8df320a54** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=39) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 39." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v39-v1 SHA-256: 7b7269b6b93124fe68ed7eee6873dd33bd9f4950ca9d0ac6c6125a44cd6fb077.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-v1"></a>

## Linaclotide DailyMed SPL version 40

> DailyMed lists Structured Product Labeling version 40 for the reviewed Linaclotide label family with a published date of 2026-10-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40:v1`
- Evidence domain: Regulatory
- Date in source: 2026-10-19
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-v1
- Content SHA-256: `4c22db185a522da459b45c5c153e396fa9dd98952fbab39912bd28e6506ec612`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 40 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history))

#### Summary

DailyMed lists Structured Product Labeling version 40 for the reviewed Linaclotide label family with a published date of 2026-10-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 40 for the reviewed Linaclotide label family with a published date of 2026-10-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 40 · published 2026-10-19 · retained ZIP SHA-256 39f73b41ea9e71d542ceb8fb5200a704ff9e2c3edd412545dbd544ddaea2bf03** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=40) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 40." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v40-v1 SHA-256: 4c22db185a522da459b45c5c153e396fa9dd98952fbab39912bd28e6506ec612.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-v1"></a>

## Linaclotide DailyMed SPL version 4

> DailyMed lists Structured Product Labeling version 4 for the reviewed Linaclotide label family with a published date of 2013-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4:v1`
- Evidence domain: Regulatory
- Date in source: 2013-04-12
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-v1
- Content SHA-256: `6bf4795d0615cdd49a1c8069d0ae728916a55b5b8f09f7c406c6b46602782ceb`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 4 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history))

#### Summary

DailyMed lists Structured Product Labeling version 4 for the reviewed Linaclotide label family with a published date of 2013-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 4 for the reviewed Linaclotide label family with a published date of 2013-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 4 · published 2013-04-12 · retained ZIP SHA-256 76086c6fffce522dba8e28c4f1e5c81502d764ee0a5549b432d445a4155f078c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=4) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 4." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v4-v1 SHA-256: 6bf4795d0615cdd49a1c8069d0ae728916a55b5b8f09f7c406c6b46602782ceb.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-v1"></a>

## Linaclotide DailyMed SPL version 5

> DailyMed lists Structured Product Labeling version 5 for the reviewed Linaclotide label family with a published date of 2013-08-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5:v1`
- Evidence domain: Regulatory
- Date in source: 2013-08-06
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-v1
- Content SHA-256: `5523b04965af062090d05d4f96f421a0845126b74e3c076230e1bb6fe33414d9`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 5 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history))

#### Summary

DailyMed lists Structured Product Labeling version 5 for the reviewed Linaclotide label family with a published date of 2013-08-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 5 for the reviewed Linaclotide label family with a published date of 2013-08-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 5 · published 2013-08-06 · retained ZIP SHA-256 88136903d3fee58fc99efacd23940693a979f32c40a56487c777fc5e25411419** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=5) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 5." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v5-v1 SHA-256: 5523b04965af062090d05d4f96f421a0845126b74e3c076230e1bb6fe33414d9.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-v1"></a>

## Linaclotide DailyMed SPL version 6

> DailyMed lists Structured Product Labeling version 6 for the reviewed Linaclotide label family with a published date of 2014-07-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6:v1`
- Evidence domain: Regulatory
- Date in source: 2014-07-16
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-v1
- Content SHA-256: `9fbc11a10045987150493a6f5e2002b055bc0b93f9c40f70b80b02e69f19b83a`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 6 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history))

#### Summary

DailyMed lists Structured Product Labeling version 6 for the reviewed Linaclotide label family with a published date of 2014-07-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 6 for the reviewed Linaclotide label family with a published date of 2014-07-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 6 · published 2014-07-16 · retained ZIP SHA-256 1609ebfc1dd6d7baffa9c8a202c733caf797afd283a91be73c3bfd973448bec9** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=6) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 6." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v6-v1 SHA-256: 9fbc11a10045987150493a6f5e2002b055bc0b93f9c40f70b80b02e69f19b83a.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-v1"></a>

## Linaclotide DailyMed SPL version 7

> DailyMed lists Structured Product Labeling version 7 for the reviewed Linaclotide label family with a published date of 2014-07-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7:v1`
- Evidence domain: Regulatory
- Date in source: 2014-07-17
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-v1
- Content SHA-256: `a42c2f4b39a0dc264dd9a06f321167883120e74017bb5d69af6b7e57c51a1f5b`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 7 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history))

#### Summary

DailyMed lists Structured Product Labeling version 7 for the reviewed Linaclotide label family with a published date of 2014-07-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 7 for the reviewed Linaclotide label family with a published date of 2014-07-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 7 · published 2014-07-17 · retained ZIP SHA-256 0c26ff1252a3dd1e7d34732bd7dc1a1c87ea32e9c662230351beb69acbd15827** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=7) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 7." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v7-v1 SHA-256: a42c2f4b39a0dc264dd9a06f321167883120e74017bb5d69af6b7e57c51a1f5b.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-v1"></a>

## Linaclotide DailyMed SPL version 8

> DailyMed lists Structured Product Labeling version 8 for the reviewed Linaclotide label family with a published date of 2015-12-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8:v1`
- Evidence domain: Regulatory
- Date in source: 2015-12-04
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-v1
- Content SHA-256: `fdf923d3511cf76957b017cde9c36376941eade300ddfbe2c74b723b549eac60`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 8 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history))

#### Summary

DailyMed lists Structured Product Labeling version 8 for the reviewed Linaclotide label family with a published date of 2015-12-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 8 for the reviewed Linaclotide label family with a published date of 2015-12-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 8 · published 2015-12-04 · retained ZIP SHA-256 6d428b99228f15983c13b89db7c35f0863ba203cebdbcf026e49c2b6e3f26f85** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=8) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 8." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v8-v1 SHA-256: fdf923d3511cf76957b017cde9c36376941eade300ddfbe2c74b723b549eac60.

---

<a id="dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-v1"></a>

## Linaclotide DailyMed SPL version 9

> DailyMed lists Structured Product Labeling version 9 for the reviewed Linaclotide label family with a published date of 2015-12-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9:v1`
- Evidence domain: Regulatory
- Date in source: 2015-12-18
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-v1
- Content SHA-256: `beae5f84f6eafb548d2694a8d1e6d2a24a0521929c991967654ce958ed6f6154`

### Claims and source pins

#### Headline

Linaclotide DailyMed SPL version 9 ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history))

#### Summary

DailyMed lists Structured Product Labeling version 9 for the reviewed Linaclotide label family with a published date of 2015-12-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 9 for the reviewed Linaclotide label family with a published date of 2015-12-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history`](#source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history))

### Sources

<a id="source-dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history"></a>
- **DailyMed SPL SET ID 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · SPL version 9 · published 2015-12-18 · retained ZIP SHA-256 89626d02bf1e9bd69160092c76b0b35460d8c2adb8f6dc129a2144cee4314680** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3&version=9) (`dailymed-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide DailyMed SPL version 9." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#dailymed-label-linaclotide-09beda19-56d6-4a56-afdc-9a77b70b2ef3-v9-v1 SHA-256: beae5f84f6eafb548d2694a8d1e6d2a24a0521929c991967654ce958ed6f6154.

---

<a id="fda-drugs-anda209564-v1"></a>

## Drugs@FDA application ANDA209564

> The official Drugs@FDA dataset lists original submission 1 for ANDA 209564 with status AP dated 2021-02-09, and names linaclotide among the application record's active ingredients.

- Evidence object: `story:fda-drugs-anda209564:v1`
- Evidence domain: Regulatory
- Date in source: 2021-02-09
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-anda209564/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-drugs-anda209564-v1
- Content SHA-256: `7ab9c5c4eb87d499dbb3961809144ee44fab1523a8c5ab7fb98c1c331cc97cf0`

### Claims and source pins

#### Headline

Drugs@FDA application ANDA209564 ([`fda-drugs-anda209564-2021-02-09-c16b14d7f4e0`](#source-fda-drugs-anda209564-2021-02-09-c16b14d7f4e0))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for ANDA 209564 with status AP dated 2021-02-09, and names linaclotide among the application record's active ingredients. ([`fda-drugs-anda209564-2021-02-09-c16b14d7f4e0`](#source-fda-drugs-anda209564-2021-02-09-c16b14d7f4e0))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for ANDA 209564 with status AP dated 2021-02-09, and names linaclotide among the application record's active ingredients. ([`fda-drugs-anda209564-2021-02-09-c16b14d7f4e0`](#source-fda-drugs-anda209564-2021-02-09-c16b14d7f4e0))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-anda209564-2021-02-09-c16b14d7f4e0`](#source-fda-drugs-anda209564-2021-02-09-c16b14d7f4e0))

### Sources

<a id="source-fda-drugs-anda209564-2021-02-09-c16b14d7f4e0"></a>
- **Drugs@FDA application ANDA209564 · original submission status AP · 2021-02-09 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22ANDA209564%22&limit=1) (`fda-drugs-anda209564-2021-02-09-c16b14d7f4e0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application ANDA209564." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-drugs-anda209564-v1 SHA-256: 7ab9c5c4eb87d499dbb3961809144ee44fab1523a8c5ab7fb98c1c331cc97cf0.

---

<a id="fda-drugs-anda209611-v1"></a>

## Drugs@FDA application ANDA209611

> The official Drugs@FDA dataset lists original submission 1 for ANDA 209611 with status AP dated 2023-02-07, and names linaclotide among the application record's active ingredients.

- Evidence object: `story:fda-drugs-anda209611:v1`
- Evidence domain: Regulatory
- Date in source: 2023-02-07
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-anda209611/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-drugs-anda209611-v1
- Content SHA-256: `d2c9995ac22982213ed92814b5e7fd2eda3f391cbc0c5516c88eae55c43fd731`

### Claims and source pins

#### Headline

Drugs@FDA application ANDA209611 ([`fda-drugs-anda209611-2023-02-07-1f1bc2997a49`](#source-fda-drugs-anda209611-2023-02-07-1f1bc2997a49))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for ANDA 209611 with status AP dated 2023-02-07, and names linaclotide among the application record's active ingredients. ([`fda-drugs-anda209611-2023-02-07-1f1bc2997a49`](#source-fda-drugs-anda209611-2023-02-07-1f1bc2997a49))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for ANDA 209611 with status AP dated 2023-02-07, and names linaclotide among the application record's active ingredients. ([`fda-drugs-anda209611-2023-02-07-1f1bc2997a49`](#source-fda-drugs-anda209611-2023-02-07-1f1bc2997a49))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-anda209611-2023-02-07-1f1bc2997a49`](#source-fda-drugs-anda209611-2023-02-07-1f1bc2997a49))

### Sources

<a id="source-fda-drugs-anda209611-2023-02-07-1f1bc2997a49"></a>
- **Drugs@FDA application ANDA209611 · original submission status AP · 2023-02-07 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22ANDA209611%22&limit=1) (`fda-drugs-anda209611-2023-02-07-1f1bc2997a49`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application ANDA209611." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-drugs-anda209611-v1 SHA-256: d2c9995ac22982213ed92814b5e7fd2eda3f391cbc0c5516c88eae55c43fd731.

---

<a id="fda-drugs-anda211255-v1"></a>

## Drugs@FDA application ANDA211255

> The official Drugs@FDA dataset lists original submission 1 for ANDA 211255 with status AP dated 2026-09-24, and names linaclotide among the application record's active ingredients.

- Evidence object: `story:fda-drugs-anda211255:v1`
- Evidence domain: Regulatory
- Date in source: 2026-09-24
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/fda-drugs-anda211255/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-drugs-anda211255-v1
- Content SHA-256: `2b4b1decbdc7324454a00abf2e49c465c6f0711164d2448d8583b7445046474a`

### Claims and source pins

#### Headline

Drugs@FDA application ANDA211255 ([`fda-drugs-anda211255-2026-09-24-7a438a5bcc44`](#source-fda-drugs-anda211255-2026-09-24-7a438a5bcc44))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for ANDA 211255 with status AP dated 2026-09-24, and names linaclotide among the application record's active ingredients. ([`fda-drugs-anda211255-2026-09-24-7a438a5bcc44`](#source-fda-drugs-anda211255-2026-09-24-7a438a5bcc44))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for ANDA 211255 with status AP dated 2026-09-24, and names linaclotide among the application record's active ingredients. ([`fda-drugs-anda211255-2026-09-24-7a438a5bcc44`](#source-fda-drugs-anda211255-2026-09-24-7a438a5bcc44))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-anda211255-2026-09-24-7a438a5bcc44`](#source-fda-drugs-anda211255-2026-09-24-7a438a5bcc44))

### Sources

<a id="source-fda-drugs-anda211255-2026-09-24-7a438a5bcc44"></a>
- **Drugs@FDA application ANDA211255 · original submission status AP · 2026-09-24 · dataset 2026-11-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22ANDA211255%22&limit=1) (`fda-drugs-anda211255-2026-09-24-7a438a5bcc44`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application ANDA211255." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-drugs-anda211255-v1 SHA-256: 2b4b1decbdc7324454a00abf2e49c465c6f0711164d2448d8583b7445046474a.

---

<a id="fda-drugs-nda202811-v1"></a>

## Drugs@FDA application NDA202811

> The official Drugs@FDA dataset lists original submission 1 for NDA 202811 with status AP dated 2012-08-30, and names linaclotide among the application record's active ingredients.

- Evidence object: `story:fda-drugs-nda202811:v1`
- Evidence domain: Regulatory
- Date in source: 2012-08-30
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-nda202811/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-drugs-nda202811-v1
- Content SHA-256: `1bc0d99019965348593567f93ba300b507baa522b4776117740feb50c4c90575`

### Claims and source pins

#### Headline

Drugs@FDA application NDA202811 ([`fda-drugs-nda202811-2012-08-30-4be8911e4fc0`](#source-fda-drugs-nda202811-2012-08-30-4be8911e4fc0))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for NDA 202811 with status AP dated 2012-08-30, and names linaclotide among the application record's active ingredients. ([`fda-drugs-nda202811-2012-08-30-4be8911e4fc0`](#source-fda-drugs-nda202811-2012-08-30-4be8911e4fc0))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for NDA 202811 with status AP dated 2012-08-30, and names linaclotide among the application record's active ingredients. ([`fda-drugs-nda202811-2012-08-30-4be8911e4fc0`](#source-fda-drugs-nda202811-2012-08-30-4be8911e4fc0))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-nda202811-2012-08-30-4be8911e4fc0`](#source-fda-drugs-nda202811-2012-08-30-4be8911e4fc0))

### Sources

<a id="source-fda-drugs-nda202811-2012-08-30-4be8911e4fc0"></a>
- **Drugs@FDA application NDA202811 · original submission status AP · 2012-08-30 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA202811%22&limit=1) (`fda-drugs-nda202811-2012-08-30-4be8911e4fc0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application NDA202811." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-drugs-nda202811-v1 SHA-256: 1bc0d99019965348593567f93ba300b507baa522b4776117740feb50c4c90575.

---

<a id="fda-enforcement-d-0417-2021-v1"></a>

## FDA enforcement report D-0417-2021

> FDA's dated enforcement report D-0417-2021 lists Class II and source status Terminated for Cardinal Health Inc. PeptideScanner connects the report to reviewed application NDA202811 through exact openFDA application-number annotations.

- Evidence object: `story:fda-enforcement-d-0417-2021:v1`
- Evidence domain: Safety
- Date in source: 2021-06-02
- Source checked: 2026-08-25
- Published by PeptideScanner: 2026-08-25
- Story landing page: https://peptidescanner.com/stories/fda-enforcement-d-0417-2021/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-enforcement-d-0417-2021-v1
- Content SHA-256: `5704c0f033c991dc79107f0e79f2db2a207e0322f4f5d8a385c0d8f22e3d7be7`

### Claims and source pins

#### Headline

FDA enforcement report D-0417-2021 ([`fda-enforcement-d-0417-2021-eb669549c560`](#source-fda-enforcement-d-0417-2021-eb669549c560))

#### Summary

FDA's dated enforcement report D-0417-2021 lists Class II and source status Terminated for Cardinal Health Inc. PeptideScanner connects the report to reviewed application NDA202811 through exact openFDA application-number annotations. ([`fda-enforcement-d-0417-2021-eb669549c560`](#source-fda-enforcement-d-0417-2021-eb669549c560))

#### Paragraph 1

FDA's dated enforcement report D-0417-2021 lists Class II and source status Terminated for Cardinal Health Inc. PeptideScanner connects the report to reviewed application NDA202811 through exact openFDA application-number annotations. ([`fda-enforcement-d-0417-2021-eb669549c560`](#source-fda-enforcement-d-0417-2021-eb669549c560))

#### Paragraph 2

FDA's source-reported reason is: CGMP Deviations: Intermittent exposure to temperature excursion during storage. ([`fda-enforcement-d-0417-2021-eb669549c560`](#source-fda-enforcement-d-0417-2021-eb669549c560))

#### Paragraph 3

This PeptideScanner lane is a bounded, dated FDA enforcement-report snapshot connected through an exact openFDA application-number annotation. It is not a medical alert or complete recall-lifecycle tracker, does not establish current product or recall status, does not identify affected lots, and does not provide medical guidance. ([`fda-enforcement-d-0417-2021-eb669549c560`](#source-fda-enforcement-d-0417-2021-eb669549c560))

### Sources

<a id="source-fda-enforcement-d-0417-2021-eb669549c560"></a>
- **FDA enforcement report D-0417-2021 · Class II · report date 2021-06-02 · source status Terminated** — FDA enforcement reports via openFDA; class A. [Open source](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0417-2021%22&limit=1) (`fda-enforcement-d-0417-2021-eb669549c560`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited safety or enforcement record. It is not an individualized risk assessment or medical recommendation.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "FDA enforcement report D-0417-2021." Version 1, published 2026-08-25. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#fda-enforcement-d-0417-2021-v1 SHA-256: 5704c0f033c991dc79107f0e79f2db2a207e0322f4f5d8a385c0d8f22e3d7be7.

---

<a id="federal-register-2014-11926-v1"></a>

## Federal Register notice 2014-11926

> The Federal Register published notice 2014-11926, attributed to FDA and its parent HHS department, on 2014-05-23. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; LINZESS,” and PeptideScanner's exact reviewed identity mapping connects the document to Linaclotide.

- Evidence object: `story:federal-register-2014-11926:v1`
- Evidence domain: Regulatory
- Date in source: 2014-05-23
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2014-11926/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#federal-register-2014-11926-v1
- Content SHA-256: `8e6dbcdb1749bda1cc705e37413f7500bbec02d1f651f77d8f21b3c6da4cbdd0`

### Claims and source pins

#### Headline

Federal Register notice 2014-11926 ([`federal-register-2014-11926-6c43dad64492`](#source-federal-register-2014-11926-6c43dad64492))

#### Summary

The Federal Register published notice 2014-11926, attributed to FDA and its parent HHS department, on 2014-05-23. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; LINZESS,” and PeptideScanner's exact reviewed identity mapping connects the document to Linaclotide. ([`federal-register-2014-11926-6c43dad64492`](#source-federal-register-2014-11926-6c43dad64492))

#### Paragraph 1

The Federal Register published notice 2014-11926, attributed to FDA and its parent HHS department, on 2014-05-23. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; LINZESS,” and PeptideScanner's exact reviewed identity mapping connects the document to Linaclotide. ([`federal-register-2014-11926-6c43dad64492`](#source-federal-register-2014-11926-6c43dad64492))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2014-11926-6c43dad64492`](#source-federal-register-2014-11926-6c43dad64492))

### Sources

<a id="source-federal-register-2014-11926-6c43dad64492"></a>
- **Federal Register notice 2014-11926 · published 2014-05-23 · Determination of Regulatory Review Period for Purposes of Patent Extension; LINZESS** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2014-05-23/pdf/2014-11926.pdf) (`federal-register-2014-11926-6c43dad64492`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2014-11926." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#federal-register-2014-11926-v1 SHA-256: 8e6dbcdb1749bda1cc705e37413f7500bbec02d1f651f77d8f21b3c6da4cbdd0.

---

<a id="federal-register-2018-28213-v1"></a>

## Federal Register notice 2018-28213

> The Federal Register published notice 2018-28213, attributed to FDA and its parent HHS department, on 2018-12-28. Its official title is “Product-Specific Guidance for Linaclotide; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Linaclotide.

- Evidence object: `story:federal-register-2018-28213:v1`
- Evidence domain: Regulatory
- Date in source: 2018-12-28
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2018-28213/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#federal-register-2018-28213-v1
- Content SHA-256: `afd66724ff54f1de7b69882bf95efbd2ca4cf268866aac9b6f66a12e347e3efc`

### Claims and source pins

#### Headline

Federal Register notice 2018-28213 ([`federal-register-2018-28213-91311667ca11`](#source-federal-register-2018-28213-91311667ca11))

#### Summary

The Federal Register published notice 2018-28213, attributed to FDA and its parent HHS department, on 2018-12-28. Its official title is “Product-Specific Guidance for Linaclotide; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Linaclotide. ([`federal-register-2018-28213-91311667ca11`](#source-federal-register-2018-28213-91311667ca11))

#### Paragraph 1

The Federal Register published notice 2018-28213, attributed to FDA and its parent HHS department, on 2018-12-28. Its official title is “Product-Specific Guidance for Linaclotide; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Linaclotide. ([`federal-register-2018-28213-91311667ca11`](#source-federal-register-2018-28213-91311667ca11))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2018-28213-91311667ca11`](#source-federal-register-2018-28213-91311667ca11))

### Sources

<a id="source-federal-register-2018-28213-91311667ca11"></a>
- **Federal Register notice 2018-28213 · published 2018-12-28 · Product-Specific Guidance for Linaclotide; Draft Guidance for Industry; Availability** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2018-12-28/pdf/2018-28213.pdf) (`federal-register-2018-28213-91311667ca11`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2018-28213." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#federal-register-2018-28213-v1 SHA-256: afd66724ff54f1de7b69882bf95efbd2ca4cf268866aac9b6f66a12e347e3efc.

---

<a id="pubmed-pmid-17694454-linaclotide-v1"></a>

## PubMed record PMID 17694454

> PeptideScanner retained PubMed bibliographic metadata for PMID 17694454 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-08-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-17694454-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17694454-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-17694454-linaclotide-v1
- Content SHA-256: `07c81726aaaab56870d8f4c0ed6007352e6379f7b405b606848e0f7a4f45b6f1`

### Claims and source pins

#### Headline

PubMed record PMID 17694454 ([`pubmed-observation-pmid-17694454-2017-11-16-849f11206924`](#source-pubmed-observation-pmid-17694454-2017-11-16-849f11206924))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 17694454 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-08-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-17694454-2017-11-16-849f11206924`](#source-pubmed-observation-pmid-17694454-2017-11-16-849f11206924))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 17694454 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-08-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-17694454-2017-11-16-849f11206924`](#source-pubmed-observation-pmid-17694454-2017-11-16-849f11206924))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17694454-2017-11-16-849f11206924`](#source-pubmed-observation-pmid-17694454-2017-11-16-849f11206924))

### Sources

<a id="source-pubmed-observation-pmid-17694454-2017-11-16-849f11206924"></a>
- **PubMed record PMID 17694454 · retained source version 1:2017-11-16:current:849f112069247589f0c8da4c7828f40ab398f2fa42a9335751a70de1b79439f6** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17694454/) (`pubmed-observation-pmid-17694454-2017-11-16-849f11206924`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 17694454." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-17694454-linaclotide-v1 SHA-256: 07c81726aaaab56870d8f4c0ed6007352e6379f7b405b606848e0f7a4f45b6f1.

---

<a id="pubmed-pmid-19098860-linaclotide-v1"></a>

## PubMed record PMID 19098860

> PeptideScanner retained PubMed bibliographic metadata for PMID 19098860 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-12-23. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-19098860-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19098860-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-19098860-linaclotide-v1
- Content SHA-256: `60805567c9df0814e211a8ba5f8cc013bbcf3f21a21fba200bd6e08f6ff8c10e`

### Claims and source pins

#### Headline

PubMed record PMID 19098860 ([`pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32`](#source-pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 19098860 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-12-23. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32`](#source-pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 19098860 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-12-23. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32`](#source-pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32`](#source-pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32))

### Sources

<a id="source-pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32"></a>
- **PubMed record PMID 19098860 · retained source version 1:2017-11-16:current:a330b60deb32490aa79d56c9e3ba28d79a9aa810825636ac25cd3c632bc7aa3f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19098860/) (`pubmed-observation-pmid-19098860-2017-11-16-a330b60deb32`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 19098860." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-19098860-linaclotide-v1 SHA-256: 60805567c9df0814e211a8ba5f8cc013bbcf3f21a21fba200bd6e08f6ff8c10e.

---

<a id="pubmed-pmid-19706070-linaclotide-v1"></a>

## PubMed record PMID 19706070

> PeptideScanner retained PubMed bibliographic metadata for PMID 19706070 at 2026-07-30T21:22:57.963Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-08-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-19706070-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19706070-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-19706070-linaclotide-v1
- Content SHA-256: `21eab99c9439f3197252dba2739930a8476b961a330b43fcdf3da4b9879faeb6`

### Claims and source pins

#### Headline

PubMed record PMID 19706070 ([`pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d`](#source-pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 19706070 at 2026-07-30T21:22:57.963Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-08-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d`](#source-pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 19706070 at 2026-07-30T21:22:57.963Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-08-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d`](#source-pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d`](#source-pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d))

### Sources

<a id="source-pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d"></a>
- **PubMed record PMID 19706070 · retained source version 1:2017-11-16:current:822e0ceaf89defd2e89610b7d7512da3e65843b757472e5cc2cf65e98c1b1bf6** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19706070/) (`pubmed-observation-pmid-19706070-2017-11-16-822e0ceaf89d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 19706070." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-19706070-linaclotide-v1 SHA-256: 21eab99c9439f3197252dba2739930a8476b961a330b43fcdf3da4b9879faeb6.

---

<a id="pubmed-pmid-20560145-linaclotide-v1"></a>

## PubMed record PMID 20560145

> PeptideScanner retained PubMed bibliographic metadata for PMID 20560145 at 2026-07-30T21:22:57.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-06-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-20560145-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20560145-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-20560145-linaclotide-v1
- Content SHA-256: `cb5c6cd92e2274856a287edbe2b1c8ed3fdf29fcd9c7e318ab3f83bdd953538c`

### Claims and source pins

#### Headline

PubMed record PMID 20560145 ([`pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa`](#source-pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 20560145 at 2026-07-30T21:22:57.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-06-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa`](#source-pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 20560145 at 2026-07-30T21:22:57.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-06-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa`](#source-pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa`](#source-pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa))

### Sources

<a id="source-pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa"></a>
- **PubMed record PMID 20560145 · retained source version 1:2017-11-16:current:412bbb408baa7aa6bf6c1f0e5ded7d7042a4aea88fec7b61d748e7b5e3ae7c0e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20560145/) (`pubmed-observation-pmid-20560145-2017-11-16-412bbb408baa`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 20560145." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-20560145-linaclotide-v1 SHA-256: cb5c6cd92e2274856a287edbe2b1c8ed3fdf29fcd9c7e318ab3f83bdd953538c.

---

<a id="pubmed-pmid-22149576-linaclotide-v1"></a>

## Clarification of trial end points presented in a recent review of linaclotide.

> PubMed lists PMID 22149576 in Expert review of gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2012-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-22149576-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-22149576-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-22149576-linaclotide-v1
- Content SHA-256: `7125b7fffe26661fd74b1b2dcb1eddb3ef483d899adadbd7f99d9d3823f477a0`

### Claims and source pins

#### Headline

Clarification of trial end points presented in a recent review of linaclotide. ([`pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d`](#source-pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d))

#### Summary

PubMed lists PMID 22149576 in Expert review of gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2012-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d`](#source-pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d))

#### Paragraph 1

PubMed lists PMID 22149576 in Expert review of gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2012-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d`](#source-pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d`](#source-pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d))

### Sources

<a id="source-pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d"></a>
- **Clarification of trial end points presented in a recent review of linaclotide. · retained source version 1:2018-12-01:current:b2b7d1063c8d1206b8c9f3f4a0b2cd9d40655bb667f0276366aa6ceecf498122** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/22149576/) (`pubmed-observation-pmid-22149576-2018-12-01-b2b7d1063c8d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Clarification of trial end points presented in a recent review of linaclotide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-22149576-linaclotide-v1 SHA-256: 7125b7fffe26661fd74b1b2dcb1eddb3ef483d899adadbd7f99d9d3823f477a0.

---

<a id="pubmed-pmid-23183319-linaclotide-v1"></a>

## Linaclotide (Linzess) for constipation.

> PubMed lists PMID 23183319 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2012-11-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23183319-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23183319-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23183319-linaclotide-v1
- Content SHA-256: `1dda24f679e08c8d80976e87db064e5261ace7ab9ca3693e78d36079e4392aa9`

### Claims and source pins

#### Headline

Linaclotide (Linzess) for constipation. ([`pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2`](#source-pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2))

#### Summary

PubMed lists PMID 23183319 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2012-11-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2`](#source-pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2))

#### Paragraph 1

PubMed lists PMID 23183319 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2012-11-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2`](#source-pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2`](#source-pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2))

### Sources

<a id="source-pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2"></a>
- **Linaclotide (Linzess) for constipation. · retained source version 1:2026-01-28:current:b553528b12e2f4d67c2d5ca784d7229b7f0f2a10724e95e6b2e5098904a451c7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23183319/) (`pubmed-observation-pmid-23183319-2026-01-28-b553528b12e2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide (Linzess) for constipation." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23183319-linaclotide-v1 SHA-256: 1dda24f679e08c8d80976e87db064e5261ace7ab9ca3693e78d36079e4392aa9.

---

<a id="pubmed-pmid-23384406-linaclotide-v1"></a>

## An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials.

> PubMed lists PMID 23384406 in Neurogastroenterology and motility as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-02-06 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23384406-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23384406-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23384406-linaclotide-v1
- Content SHA-256: `2a8871f746ade48bb737f7d43616b8ddde30b7f1fd41aacdeb8ff4f85a0cca03`

### Claims and source pins

#### Headline

An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials. ([`pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e`](#source-pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e))

#### Summary

PubMed lists PMID 23384406 in Neurogastroenterology and motility as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-02-06 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e`](#source-pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e))

#### Paragraph 1

PubMed lists PMID 23384406 in Neurogastroenterology and motility as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-02-06 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e`](#source-pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e`](#source-pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e))

### Sources

<a id="source-pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e"></a>
- **An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials. · retained source version 1:2026-01-28:current:f13eb769169ecaff2e102ebff7f8baae47ad35356ae50f4223e8fdfd256c15b5** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23384406/) (`pubmed-observation-pmid-23384406-2026-01-28-f13eb769169e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23384406-linaclotide-v1 SHA-256: 2a8871f746ade48bb737f7d43616b8ddde30b7f1fd41aacdeb8ff4f85a0cca03.

---

<a id="pubmed-pmid-23464519-linaclotide-v1"></a>

## Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs.

> PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23464519-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23464519-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23464519-linaclotide-v1
- Content SHA-256: `69e0e71e138551036ef1f00224d9da87234efe2e8b48b1d1118250ef2c28b28f`

### Claims and source pins

#### Headline

Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs. ([`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`](#source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87))

#### Summary

PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`](#source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87))

#### Paragraph 1

PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`](#source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`](#source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87))

### Sources

<a id="source-pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87"></a>
- **Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs. · retained source version 1:2017-11-16:current:99a4fbd8bc8711399024168d5fa7fbf10360fbf06bddff99eb54028943c497cf** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23464519/) (`pubmed-observation-pmid-23464519-2017-11-16-99a4fbd8bc87`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23464519-linaclotide-v1 SHA-256: 69e0e71e138551036ef1f00224d9da87234efe2e8b48b1d1118250ef2c28b28f.

---

<a id="pubmed-pmid-23791794-linaclotide-v1"></a>

## Linaclotide for the treatment of irritable bowel syndrome with constipation: is it time to reshuffle the deck?

> PubMed lists PMID 23791794 in Gastroenterology as Journal Article, Comment, with publication-date metadata of 2013-06-20 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23791794-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-02
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23791794-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23791794-linaclotide-v1
- Content SHA-256: `ae91da783bfb2f91da0e24d20e8afca1810faf17775c3c36ba299abbf7c6d0e8`

### Claims and source pins

#### Headline

Linaclotide for the treatment of irritable bowel syndrome with constipation: is it time to reshuffle the deck? ([`pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d`](#source-pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d))

#### Summary

PubMed lists PMID 23791794 in Gastroenterology as Journal Article, Comment, with publication-date metadata of 2013-06-20 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d`](#source-pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d))

#### Paragraph 1

PubMed lists PMID 23791794 in Gastroenterology as Journal Article, Comment, with publication-date metadata of 2013-06-20 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d`](#source-pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d`](#source-pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d))

### Sources

<a id="source-pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d"></a>
- **Linaclotide for the treatment of irritable bowel syndrome with constipation: is it time to reshuffle the deck? · retained source version 1:2018-12-02:current:ccaa6fe8e76d5d84797728a0f5998cef6feab9b5499d632a0345001a3a41112e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23791794/) (`pubmed-observation-pmid-23791794-2018-12-02-ccaa6fe8e76d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide for the treatment of irritable bowel syndrome with constipation: is it time to reshuffle the deck?" Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23791794-linaclotide-v1 SHA-256: ae91da783bfb2f91da0e24d20e8afca1810faf17775c3c36ba299abbf7c6d0e8.

---

<a id="pubmed-pmid-23810343-linaclotide-v1"></a>

## Clarification of linaclotide clinical trial information in a recent review on constipation.

> PubMed lists PMID 23810343 in Gastroenterology as Letter, Comment, with publication-date metadata of 2013-06-26 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23810343-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-02
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23810343-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23810343-linaclotide-v1
- Content SHA-256: `26040d214d2d4d8c06e0752e11fbd6ac5f279806f3257f934acdb3a9c151da93`

### Claims and source pins

#### Headline

Clarification of linaclotide clinical trial information in a recent review on constipation. ([`pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c`](#source-pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c))

#### Summary

PubMed lists PMID 23810343 in Gastroenterology as Letter, Comment, with publication-date metadata of 2013-06-26 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c`](#source-pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c))

#### Paragraph 1

PubMed lists PMID 23810343 in Gastroenterology as Letter, Comment, with publication-date metadata of 2013-06-26 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c`](#source-pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c`](#source-pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c))

### Sources

<a id="source-pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c"></a>
- **Clarification of linaclotide clinical trial information in a recent review on constipation. · retained source version 1:2018-12-02:current:5f9bafd3fe8c84c703a322e9a64f3eb623df1ae5ca2fde8d9c4f984091f7c8ee** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23810343/) (`pubmed-observation-pmid-23810343-2018-12-02-5f9bafd3fe8c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Clarification of linaclotide clinical trial information in a recent review on constipation." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-23810343-linaclotide-v1 SHA-256: 26040d214d2d4d8c06e0752e11fbd6ac5f279806f3257f934acdb3a9c151da93.

---

<a id="pubmed-pmid-24090017-linaclotide-v1"></a>

## Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity.

> PubMed lists PMID 24090017 in Revista espanola de enfermedades digestivas as Journal Article, Review, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24090017-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-09-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24090017-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-24090017-linaclotide-v1
- Content SHA-256: `34b717d641c39d2c928bf2694492ef57e9a6d5dbf4a9d2c3420e54280c621227`

### Claims and source pins

#### Headline

Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity. ([`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`](#source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617))

#### Summary

PubMed lists PMID 24090017 in Revista espanola de enfermedades digestivas as Journal Article, Review, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`](#source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617))

#### Paragraph 1

PubMed lists PMID 24090017 in Revista espanola de enfermedades digestivas as Journal Article, Review, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`](#source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`](#source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617))

### Sources

<a id="source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617"></a>
- **Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity. · retained source version 1:2019-09-18:current:022cb5dad6179fb61acdf11c0e13a066135cd953906443075de52f235f884880** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24090017/) (`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-24090017-linaclotide-v1 SHA-256: 34b717d641c39d2c928bf2694492ef57e9a6d5dbf4a9d2c3420e54280c621227.

---

<a id="pubmed-pmid-24227771-linaclotide-v1"></a>

## Linaclotide for constipation-predominant IBS.

> PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24227771-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24227771-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-24227771-linaclotide-v1
- Content SHA-256: `678cd4b84e982eccfea0d3067df16149d9c81ad4284c64943af17dedce5a2e4a`

### Claims and source pins

#### Headline

Linaclotide for constipation-predominant IBS. ([`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`](#source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e))

#### Summary

PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`](#source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e))

#### Paragraph 1

PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`](#source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`](#source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e))

### Sources

<a id="source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e"></a>
- **Linaclotide for constipation-predominant IBS. · retained source version 1:2017-11-16:current:616667c7d06ee2b038eb278b4f4e928b825290e2099b5523b5c4f465a3045b0f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24227771/) (`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide for constipation-predominant IBS." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-24227771-linaclotide-v1 SHA-256: 678cd4b84e982eccfea0d3067df16149d9c81ad4284c64943af17dedce5a2e4a.

---

<a id="pubmed-pmid-25333331-linaclotide-v1"></a>

## Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.

> PubMed lists PMID 25333331 in Journal of medical economics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-25333331-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25333331-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-25333331-linaclotide-v1
- Content SHA-256: `4a14cb610501053ae91738c8a5805268390ff994e9acc7394f16e9b530a9b4e5`

### Claims and source pins

#### Headline

Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States. ([`pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf`](#source-pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf))

#### Summary

PubMed lists PMID 25333331 in Journal of medical economics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf`](#source-pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf))

#### Paragraph 1

PubMed lists PMID 25333331 in Journal of medical economics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf`](#source-pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf`](#source-pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf))

### Sources

<a id="source-pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf"></a>
- **Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States. · retained source version 1:2017-11-16:current:0f509b4c93cf79d8aea790d5ca3575de92b8b6f8b20039cdcfc86a23f1a14499** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25333331/) (`pubmed-observation-pmid-25333331-2017-11-16-0f509b4c93cf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-25333331-linaclotide-v1 SHA-256: 4a14cb610501053ae91738c8a5805268390ff994e9acc7394f16e9b530a9b4e5.

---

<a id="pubmed-pmid-27008836-linaclotide-v1"></a>

## Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States.

> PubMed lists PMID 27008836 in Managed care (Langhorne, Pa.) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27008836-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27008836-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-27008836-linaclotide-v1
- Content SHA-256: `1a05620467dfc1fb100e3916f4a8588aca49925ceab9e285d238057dd56cdd6f`

### Claims and source pins

#### Headline

Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States. ([`pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e`](#source-pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e))

#### Summary

PubMed lists PMID 27008836 in Managed care (Langhorne, Pa.) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e`](#source-pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e))

#### Paragraph 1

PubMed lists PMID 27008836 in Managed care (Langhorne, Pa.) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e`](#source-pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e`](#source-pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e))

### Sources

<a id="source-pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e"></a>
- **Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States. · retained source version 1:2026-01-27:current:1c6768fba05e07af95b8218e5e71712114656a19a9db4a623557f6075bd95041** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27008836/) (`pubmed-observation-pmid-27008836-2026-01-27-1c6768fba05e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-27008836-linaclotide-v1 SHA-256: 1a05620467dfc1fb100e3916f4a8588aca49925ceab9e285d238057dd56cdd6f.

---

<a id="pubmed-pmid-27200765-linaclotide-v1"></a>

## PubMed record PMID 27200765

> PeptideScanner retained PubMed bibliographic metadata for PMID 27200765 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-27200765-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-05-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27200765-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-27200765-linaclotide-v1
- Content SHA-256: `77042838f0702a3f249bc1cd592fc9323e47e1ad5ba2d2a135eccca1815fc5b0`

### Claims and source pins

#### Headline

PubMed record PMID 27200765 ([`pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6`](#source-pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 27200765 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6`](#source-pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 27200765 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6`](#source-pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6`](#source-pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6))

### Sources

<a id="source-pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6"></a>
- **PubMed record PMID 27200765 · retained source version 1:2016-05-21:current:dac7145405f6119187df46c7713bcce72f1001a392f4092ee6093bf09e012ff1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27200765/) (`pubmed-observation-pmid-27200765-2016-05-21-dac7145405f6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 27200765." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-27200765-linaclotide-v1 SHA-256: 77042838f0702a3f249bc1cd592fc9323e47e1ad5ba2d2a135eccca1815fc5b0.

---

<a id="pubmed-pmid-28396341-linaclotide-v1"></a>

## Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.

> PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-28396341-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-01-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28396341-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-28396341-linaclotide-v1
- Content SHA-256: `3dd06e8f7268d33ef2cc697fba74909f4a4f16955b8928ec99cec661468e5bb4`

### Claims and source pins

#### Headline

Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. ([`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`](#source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9))

#### Summary

PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`](#source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9))

#### Paragraph 1

PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`](#source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`](#source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9))

### Sources

<a id="source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9"></a>
- **Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. · retained source version 1:2025-01-03:current:628404c7fcb96bf4b9797b5cfda9d78acda3083d570ad69a5a2404240b889574** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28396341/) (`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-28396341-linaclotide-v1 SHA-256: 3dd06e8f7268d33ef2cc697fba74909f4a4f16955b8928ec99cec661468e5bb4.

---

<a id="pubmed-pmid-29184433-linaclotide-v1"></a>

## Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide.

> PubMed lists PMID 29184433 in International journal of general medicine as Journal Article, Review, with publication-date metadata of 2017-10-31 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29184433-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-03-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29184433-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-29184433-linaclotide-v1
- Content SHA-256: `ad6099024ada3d07744fd83386c13578b6bdaac9c8b4ab92aef253427c363695`

### Claims and source pins

#### Headline

Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide. ([`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`](#source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6))

#### Summary

PubMed lists PMID 29184433 in International journal of general medicine as Journal Article, Review, with publication-date metadata of 2017-10-31 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`](#source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6))

#### Paragraph 1

PubMed lists PMID 29184433 in International journal of general medicine as Journal Article, Review, with publication-date metadata of 2017-10-31 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`](#source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`](#source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6))

### Sources

<a id="source-pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6"></a>
- **Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide. · retained source version 1:2024-03-27:current:f752f49a1ea67ab8c7816615e9f540360698d9f1bf9fd7ea51eaee234991c325** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29184433/) (`pubmed-observation-pmid-29184433-2024-03-27-f752f49a1ea6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-29184433-linaclotide-v1 SHA-256: ad6099024ada3d07744fd83386c13578b6bdaac9c8b4ab92aef253427c363695.

---

<a id="pubmed-pmid-29451468-linaclotide-v1"></a>

## Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population.

> PubMed lists PMID 29451468 in Managed care (Langhorne, Pa.) as Journal Article, with publication-date metadata of 2018-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29451468-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29451468-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-29451468-linaclotide-v1
- Content SHA-256: `c642f8fb4da0bc93db76b1cf0784e678c46dbbc049e480820a318ba4868f5574`

### Claims and source pins

#### Headline

Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population. ([`pubmed-observation-pmid-29451468-2026-01-27-29289767d64c`](#source-pubmed-observation-pmid-29451468-2026-01-27-29289767d64c))

#### Summary

PubMed lists PMID 29451468 in Managed care (Langhorne, Pa.) as Journal Article, with publication-date metadata of 2018-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29451468-2026-01-27-29289767d64c`](#source-pubmed-observation-pmid-29451468-2026-01-27-29289767d64c))

#### Paragraph 1

PubMed lists PMID 29451468 in Managed care (Langhorne, Pa.) as Journal Article, with publication-date metadata of 2018-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29451468-2026-01-27-29289767d64c`](#source-pubmed-observation-pmid-29451468-2026-01-27-29289767d64c))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29451468-2026-01-27-29289767d64c`](#source-pubmed-observation-pmid-29451468-2026-01-27-29289767d64c))

### Sources

<a id="source-pubmed-observation-pmid-29451468-2026-01-27-29289767d64c"></a>
- **Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population. · retained source version 1:2026-01-27:current:29289767d64c091c0d5be19586103dc4b34608643fb9b8f2e8eb10e0d0e6f82c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29451468/) (`pubmed-observation-pmid-29451468-2026-01-27-29289767d64c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-29451468-linaclotide-v1 SHA-256: c642f8fb4da0bc93db76b1cf0784e678c46dbbc049e480820a318ba4868f5574.

---

<a id="pubmed-pmid-29985664-linaclotide-v1"></a>

## Linaclotide for the treatment of chronic constipation.

> PubMed lists PMID 29985664 in Expert opinion on pharmacotherapy as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-07-09 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29985664-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-03-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29985664-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-29985664-linaclotide-v1
- Content SHA-256: `dde60c96665c9a4cc0a69556b582e6c3c5abd27000860078c3b4117cd6d40edf`

### Claims and source pins

#### Headline

Linaclotide for the treatment of chronic constipation. ([`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`](#source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278))

#### Summary

PubMed lists PMID 29985664 in Expert opinion on pharmacotherapy as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-07-09 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`](#source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278))

#### Paragraph 1

PubMed lists PMID 29985664 in Expert opinion on pharmacotherapy as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-07-09 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`](#source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`](#source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278))

### Sources

<a id="source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278"></a>
- **Linaclotide for the treatment of chronic constipation. · retained source version 1:2019-03-18:current:0daca531a2782f955cd8beedbf98674eb121ba0eb85a5b35e297b542d270732c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29985664/) (`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide for the treatment of chronic constipation." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-29985664-linaclotide-v1 SHA-256: dde60c96665c9a4cc0a69556b582e6c3c5abd27000860078c3b4117cd6d40edf.

---

<a id="pubmed-pmid-30301200-linaclotide-v1"></a>

## Engineering of an Anti-Inflammatory Peptide Based on the Disulfide-Rich Linaclotide Scaffold.

> PubMed lists PMID 30301200 in Biomedicines as Journal Article, with publication-date metadata of 2018-10-06 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30301200-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-09-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30301200-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-30301200-linaclotide-v1
- Content SHA-256: `18825d6c908b7a054b0f1fc8d3e4b9e8d9ed80f683ff567d7754fd96c919518e`

### Claims and source pins

#### Headline

Engineering of an Anti-Inflammatory Peptide Based on the Disulfide-Rich Linaclotide Scaffold. ([`pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80`](#source-pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80))

#### Summary

PubMed lists PMID 30301200 in Biomedicines as Journal Article, with publication-date metadata of 2018-10-06 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80`](#source-pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80))

#### Paragraph 1

PubMed lists PMID 30301200 in Biomedicines as Journal Article, with publication-date metadata of 2018-10-06 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80`](#source-pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80`](#source-pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80))

### Sources

<a id="source-pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80"></a>
- **Engineering of an Anti-Inflammatory Peptide Based on the Disulfide-Rich Linaclotide Scaffold. · retained source version 1:2020-09-30:current:bdb2b05dde80fc7eb312e3495e0021dfe70f02a71ba44f30a2ca86c85a2e1f3b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30301200/) (`pubmed-observation-pmid-30301200-2020-09-30-bdb2b05dde80`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Engineering of an Anti-Inflammatory Peptide Based on the Disulfide-Rich Linaclotide Scaffold." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-30301200-linaclotide-v1 SHA-256: 18825d6c908b7a054b0f1fc8d3e4b9e8d9ed80f683ff567d7754fd96c919518e.

---

<a id="pubmed-pmid-30302125-linaclotide-v1"></a>

## UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation.

> PubMed lists PMID 30302125 in Therapeutic advances in gastroenterology as Journal Article, with publication-date metadata of 2018-10-03 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30302125-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-09-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30302125-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-30302125-linaclotide-v1
- Content SHA-256: `1a489c68aedcb4ab71d25f359938baf2ee2798f72846a1ec4768f5faa93d09c8`

### Claims and source pins

#### Headline

UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation. ([`pubmed-observation-pmid-30302125-2023-09-28-db7f66789558`](#source-pubmed-observation-pmid-30302125-2023-09-28-db7f66789558))

#### Summary

PubMed lists PMID 30302125 in Therapeutic advances in gastroenterology as Journal Article, with publication-date metadata of 2018-10-03 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30302125-2023-09-28-db7f66789558`](#source-pubmed-observation-pmid-30302125-2023-09-28-db7f66789558))

#### Paragraph 1

PubMed lists PMID 30302125 in Therapeutic advances in gastroenterology as Journal Article, with publication-date metadata of 2018-10-03 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30302125-2023-09-28-db7f66789558`](#source-pubmed-observation-pmid-30302125-2023-09-28-db7f66789558))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30302125-2023-09-28-db7f66789558`](#source-pubmed-observation-pmid-30302125-2023-09-28-db7f66789558))

### Sources

<a id="source-pubmed-observation-pmid-30302125-2023-09-28-db7f66789558"></a>
- **UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation. · retained source version 1:2023-09-28:current:db7f6678955830dcf979c2ada0c8b15fb36e6f01b20f62a92673fcc5d4070320** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30302125/) (`pubmed-observation-pmid-30302125-2023-09-28-db7f66789558`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-30302125-linaclotide-v1 SHA-256: 1a489c68aedcb4ab71d25f359938baf2ee2798f72846a1ec4768f5faa93d09c8.

---

<a id="pubmed-pmid-30470553-linaclotide-v1"></a>

## Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome.

> PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30470553-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-06-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30470553-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-30470553-linaclotide-v1
- Content SHA-256: `51ecbcfbcc36148a7f41831fd7c542e21bef03bd6ceec3b89013424506773ba7`

### Claims and source pins

#### Headline

Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome. ([`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`](#source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160))

#### Summary

PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`](#source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160))

#### Paragraph 1

PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`](#source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`](#source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160))

### Sources

<a id="source-pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160"></a>
- **Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome. · retained source version 1:2019-06-13:current:14e2cd939160719beb7a660d9f0c77e181cca2acc1b15db047be2e1ffef96943** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30470553/) (`pubmed-observation-pmid-30470553-2019-06-13-14e2cd939160`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-30470553-linaclotide-v1 SHA-256: 51ecbcfbcc36148a7f41831fd7c542e21bef03bd6ceec3b89013424506773ba7.

---

<a id="pubmed-pmid-30746404-linaclotide-v1"></a>

## Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism.

> PubMed lists PMID 30746404 in Movement disorders clinical practice as Journal Article, with publication-date metadata of 2018-01-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30746404-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-09-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30746404-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-30746404-linaclotide-v1
- Content SHA-256: `e7448610b22043d9b9f42fed2e18a3ed0f77d0c8ec76940f2e47373aea1e94c4`

### Claims and source pins

#### Headline

Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism. ([`pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7`](#source-pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7))

#### Summary

PubMed lists PMID 30746404 in Movement disorders clinical practice as Journal Article, with publication-date metadata of 2018-01-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7`](#source-pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7))

#### Paragraph 1

PubMed lists PMID 30746404 in Movement disorders clinical practice as Journal Article, with publication-date metadata of 2018-01-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7`](#source-pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7`](#source-pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7))

### Sources

<a id="source-pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7"></a>
- **Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism. · retained source version 1:2020-09-30:current:3ef14f6b75b75b0bd4ff2e081ee1f1bb4f7524e0444d5b99e1b23b74c1477b2f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30746404/) (`pubmed-observation-pmid-30746404-2020-09-30-3ef14f6b75b7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-30746404-linaclotide-v1 SHA-256: e7448610b22043d9b9f42fed2e18a3ed0f77d0c8ec76940f2e47373aea1e94c4.

---

<a id="pubmed-pmid-32863841-linaclotide-v1"></a>

## Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States.

> PubMed lists PMID 32863841 in Drugs in context as Journal Article, with publication-date metadata of 2020-08-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32863841-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-11-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32863841-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-32863841-linaclotide-v1
- Content SHA-256: `bc88a6053cde28a87a13aa6b2069bcc297a6068a83551144c5be7da0a1e0025b`

### Claims and source pins

#### Headline

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States. ([`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`](#source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38))

#### Summary

PubMed lists PMID 32863841 in Drugs in context as Journal Article, with publication-date metadata of 2020-08-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`](#source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38))

#### Paragraph 1

PubMed lists PMID 32863841 in Drugs in context as Journal Article, with publication-date metadata of 2020-08-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`](#source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`](#source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38))

### Sources

<a id="source-pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38"></a>
- **Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States. · retained source version 1:2023-11-12:current:8489278e6d3874ece29b81e528b94fd4343163aa492f68683f6bf58c6d27e0de** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32863841/) (`pubmed-observation-pmid-32863841-2023-11-12-8489278e6d38`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-32863841-linaclotide-v1 SHA-256: bc88a6053cde28a87a13aa6b2069bcc297a6068a83551144c5be7da0a1e0025b.

---

<a id="pubmed-pmid-33858329-linaclotide-v1"></a>

## PubMed record PMID 33858329

> PeptideScanner retained PubMed bibliographic metadata for PMID 33858329 at 2026-07-30T16:22:11.958Z. PubMed recorded a metadata revision date of 2026-04-06 and an Entrez history date of 2021-04-16. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-33858329-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33858329-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-33858329-linaclotide-v1
- Content SHA-256: `4683a30fa29708da75542822f214a846f2c57494e599bb90a2dae8a03e918587`

### Claims and source pins

#### Headline

PubMed record PMID 33858329 ([`pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f`](#source-pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 33858329 at 2026-07-30T16:22:11.958Z. PubMed recorded a metadata revision date of 2026-04-06 and an Entrez history date of 2021-04-16. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f`](#source-pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 33858329 at 2026-07-30T16:22:11.958Z. PubMed recorded a metadata revision date of 2026-04-06 and an Entrez history date of 2021-04-16. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f`](#source-pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f`](#source-pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f))

### Sources

<a id="source-pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f"></a>
- **PubMed record PMID 33858329 · retained source version 1:2026-04-06:current:42a62e0c936f4472d1509498782c286527c98162c91b367b7ee5defc3e01c110** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33858329/) (`pubmed-observation-pmid-33858329-2026-04-06-42a62e0c936f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 33858329." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-33858329-linaclotide-v1 SHA-256: 4683a30fa29708da75542822f214a846f2c57494e599bb90a2dae8a03e918587.

---

<a id="pubmed-pmid-36565004-linaclotide-v1"></a>

## Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome.

> PubMed lists PMID 36565004 in Alimentary pharmacology & therapeutics as Editorial, Comment, with publication-date metadata of 2023-01 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36565004-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-02-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36565004-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-36565004-linaclotide-v1
- Content SHA-256: `014e4b00137c7b9d654865b36b9b1d7623a2e644df6e21d7e1e702f885bed54d`

### Claims and source pins

#### Headline

Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome. ([`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`](#source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d))

#### Summary

PubMed lists PMID 36565004 in Alimentary pharmacology & therapeutics as Editorial, Comment, with publication-date metadata of 2023-01 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`](#source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d))

#### Paragraph 1

PubMed lists PMID 36565004 in Alimentary pharmacology & therapeutics as Editorial, Comment, with publication-date metadata of 2023-01 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`](#source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`](#source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d))

### Sources

<a id="source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d"></a>
- **Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome. · retained source version 1:2023-02-26:current:d432cc74866dc520e09ffc1f10685e17cc6399b5a5fe3aab3284c91a636d8662** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36565004/) (`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-36565004-linaclotide-v1 SHA-256: 014e4b00137c7b9d654865b36b9b1d7623a2e644df6e21d7e1e702f885bed54d.

---

<a id="pubmed-pmid-37651297-linaclotide-v1"></a>

## Linaclotide (Linzess) for functional constipation.

> PubMed lists PMID 37651297 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2023-08-21 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-37651297-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-09-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-37651297-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-37651297-linaclotide-v1
- Content SHA-256: `f85dcf819dc7856ef068f6f26da4f2bd6235082e65655aa43368ed9a527d812d`

### Claims and source pins

#### Headline

Linaclotide (Linzess) for functional constipation. ([`pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9`](#source-pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9))

#### Summary

PubMed lists PMID 37651297 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2023-08-21 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9`](#source-pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9))

#### Paragraph 1

PubMed lists PMID 37651297 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2023-08-21 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9`](#source-pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9`](#source-pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9))

### Sources

<a id="source-pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9"></a>
- **Linaclotide (Linzess) for functional constipation. · retained source version 1:2023-09-05:current:57254ae959e95992531467de5b8f45be7376f6ec412ff17a24be8cfa8a85230b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/37651297/) (`pubmed-observation-pmid-37651297-2023-09-05-57254ae959e9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide (Linzess) for functional constipation." Version 1, published 2026-08-16. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-37651297-linaclotide-v1 SHA-256: f85dcf819dc7856ef068f6f26da4f2bd6235082e65655aa43368ed9a527d812d.

---

<a id="pubmed-pmid-38159221-linaclotide-v1"></a>

## PubMed record PMID 38159221

> PeptideScanner retained PubMed bibliographic metadata for PMID 38159221 at 2026-07-30T16:20:36.597Z. PubMed recorded a metadata revision date of 2026-05-15 and an Entrez history date of 2023-12-30. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38159221-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38159221-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38159221-linaclotide-v1
- Content SHA-256: `af54e35c42b4481e55261334a874bc7e3b4496bb506d4615db5d895eb522ad48`

### Claims and source pins

#### Headline

PubMed record PMID 38159221 ([`pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5`](#source-pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38159221 at 2026-07-30T16:20:36.597Z. PubMed recorded a metadata revision date of 2026-05-15 and an Entrez history date of 2023-12-30. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5`](#source-pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38159221 at 2026-07-30T16:20:36.597Z. PubMed recorded a metadata revision date of 2026-05-15 and an Entrez history date of 2023-12-30. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5`](#source-pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5`](#source-pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5))

### Sources

<a id="source-pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5"></a>
- **PubMed record PMID 38159221 · retained source version 1:2026-05-15:current:6d32473379e55d6b582df233275be2da515d0cfe3272fb6dfc3d20209d150f7b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38159221/) (`pubmed-observation-pmid-38159221-2026-05-15-6d32473379e5`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38159221." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38159221-linaclotide-v1 SHA-256: af54e35c42b4481e55261334a874bc7e3b4496bb506d4615db5d895eb522ad48.

---

<a id="pubmed-pmid-38211605-linaclotide-v1"></a>

## Linaclotide for paediatric functional constipation.

> PubMed lists PMID 38211605 in The lancet. Gastroenterology & hepatology as Journal Article, Comment, with publication-date metadata of 2024-01-08 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38211605-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-06-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38211605-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38211605-linaclotide-v1
- Content SHA-256: `60b90ed29bcec1c14baf7c6c8ad72857ee87542f1a071d03f05a16b5ae7d27ff`

### Claims and source pins

#### Headline

Linaclotide for paediatric functional constipation. ([`pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df`](#source-pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df))

#### Summary

PubMed lists PMID 38211605 in The lancet. Gastroenterology & hepatology as Journal Article, Comment, with publication-date metadata of 2024-01-08 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df`](#source-pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df))

#### Paragraph 1

PubMed lists PMID 38211605 in The lancet. Gastroenterology & hepatology as Journal Article, Comment, with publication-date metadata of 2024-01-08 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df`](#source-pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df`](#source-pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df))

### Sources

<a id="source-pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df"></a>
- **Linaclotide for paediatric functional constipation. · retained source version 1:2025-06-05:current:5fbbd4f896df1cb21d7e837a8bea95fd2733a31367dc6c52c9be05671efd4933** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38211605/) (`pubmed-observation-pmid-38211605-2025-06-05-5fbbd4f896df`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide for paediatric functional constipation." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38211605-linaclotide-v1 SHA-256: 60b90ed29bcec1c14baf7c6c8ad72857ee87542f1a071d03f05a16b5ae7d27ff.

---

<a id="pubmed-pmid-38533633-linaclotide-v1"></a>

## PubMed record PMID 38533633

> PeptideScanner retained PubMed bibliographic metadata for PMID 38533633 at 2026-07-30T16:14:06.902Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2024-03-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38533633-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38533633-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38533633-linaclotide-v1
- Content SHA-256: `baf540a8359e7fb496e7f62303ad023bea489547967c8bdeed0f272184dd645c`

### Claims and source pins

#### Headline

PubMed record PMID 38533633 ([`pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d`](#source-pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38533633 at 2026-07-30T16:14:06.902Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2024-03-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d`](#source-pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38533633 at 2026-07-30T16:14:06.902Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2024-03-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d`](#source-pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d`](#source-pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d))

### Sources

<a id="source-pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d"></a>
- **PubMed record PMID 38533633 · retained source version 1:2026-06-26:current:73db373ac48dbe27d1818fdcc4986b96f2aa0d974248de66f2e2f2e2f915ca25** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38533633/) (`pubmed-observation-pmid-38533633-2026-06-26-73db373ac48d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38533633." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38533633-linaclotide-v1 SHA-256: baf540a8359e7fb496e7f62303ad023bea489547967c8bdeed0f272184dd645c.

---

<a id="pubmed-pmid-38869953-linaclotide-v1"></a>

## PubMed record PMID 38869953

> PeptideScanner retained PubMed bibliographic metadata for PMID 38869953 at 2026-07-30T16:14:08.743Z. PubMed recorded a metadata revision date of 2026-06-16 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38869953-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38869953-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38869953-linaclotide-v1
- Content SHA-256: `96ff9041b2f3d8121326a62d48865dd14dff77c13bd07ab18f81fcd4e50a4eda`

### Claims and source pins

#### Headline

PubMed record PMID 38869953 ([`pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc`](#source-pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38869953 at 2026-07-30T16:14:08.743Z. PubMed recorded a metadata revision date of 2026-06-16 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc`](#source-pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38869953 at 2026-07-30T16:14:08.743Z. PubMed recorded a metadata revision date of 2026-06-16 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc`](#source-pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc`](#source-pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc))

### Sources

<a id="source-pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc"></a>
- **PubMed record PMID 38869953 · retained source version 1:2026-06-16:current:9cdcf461a6fc3f07e4f531c806e90da9da510c3e80ccfc01bddb33839dc289bd** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38869953/) (`pubmed-observation-pmid-38869953-2026-06-16-9cdcf461a6fc`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38869953." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38869953-linaclotide-v1 SHA-256: 96ff9041b2f3d8121326a62d48865dd14dff77c13bd07ab18f81fcd4e50a4eda.

---

<a id="pubmed-pmid-38962910-linaclotide-v1"></a>

## PubMed record PMID 38962910

> PeptideScanner retained PubMed bibliographic metadata for PMID 38962910 at 2026-08-10T18:13:32.376Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2024-07-04. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38962910-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-23
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38962910-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38962910-linaclotide-v1
- Content SHA-256: `b3a4375395e96a86b2a488f0e96a289c65fc821b581b52c8a4b10312b9e3d730`

### Claims and source pins

#### Headline

PubMed record PMID 38962910 ([`pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f`](#source-pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38962910 at 2026-08-10T18:13:32.376Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2024-07-04. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f`](#source-pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38962910 at 2026-08-10T18:13:32.376Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2024-07-04. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f`](#source-pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f`](#source-pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f))

### Sources

<a id="source-pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f"></a>
- **PubMed record PMID 38962910 · retained source version 1:2026-07-23:current:5bcec0b7eb1f0a1b90ce0723466a4527641eb40d40f404b7df04dcf78ea80ca0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38962910/) (`pubmed-observation-pmid-38962910-2026-07-23-5bcec0b7eb1f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38962910." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-38962910-linaclotide-v1 SHA-256: b3a4375395e96a86b2a488f0e96a289c65fc821b581b52c8a4b10312b9e3d730.

---

<a id="pubmed-pmid-39370607-linaclotide-v1"></a>

## PubMed record PMID 39370607

> PeptideScanner retained PubMed bibliographic metadata for PMID 39370607 at 2026-07-30T16:11:44.834Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-10-07. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39370607-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39370607-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39370607-linaclotide-v1
- Content SHA-256: `65dcf51733bb5e0a2e170e0fafdbdefcf53ea5855cdd6991f5ed6274248c6cc9`

### Claims and source pins

#### Headline

PubMed record PMID 39370607 ([`pubmed-observation-pmid-39370607-2026-07-01-20ce26653656`](#source-pubmed-observation-pmid-39370607-2026-07-01-20ce26653656))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39370607 at 2026-07-30T16:11:44.834Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-10-07. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39370607-2026-07-01-20ce26653656`](#source-pubmed-observation-pmid-39370607-2026-07-01-20ce26653656))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39370607 at 2026-07-30T16:11:44.834Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-10-07. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39370607-2026-07-01-20ce26653656`](#source-pubmed-observation-pmid-39370607-2026-07-01-20ce26653656))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39370607-2026-07-01-20ce26653656`](#source-pubmed-observation-pmid-39370607-2026-07-01-20ce26653656))

### Sources

<a id="source-pubmed-observation-pmid-39370607-2026-07-01-20ce26653656"></a>
- **PubMed record PMID 39370607 · retained source version 1:2026-07-01:current:20ce2665365606b3b6e7a696b7c7f43863acd1e61a91b61180205050570e25d9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39370607/) (`pubmed-observation-pmid-39370607-2026-07-01-20ce26653656`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39370607." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39370607-linaclotide-v1 SHA-256: 65dcf51733bb5e0a2e170e0fafdbdefcf53ea5855cdd6991f5ed6274248c6cc9.

---

<a id="pubmed-pmid-39427438-linaclotide-v1"></a>

## Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS.

> PubMed lists PMID 39427438 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2024-10-17 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39427438-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39427438-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39427438-linaclotide-v1
- Content SHA-256: `f24564a5636f424601fc0fe8d9349465f3f69dd33c0d9b8c869a15df910e1b5e`

### Claims and source pins

#### Headline

Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS. ([`pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa`](#source-pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa))

#### Summary

PubMed lists PMID 39427438 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2024-10-17 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa`](#source-pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa))

#### Paragraph 1

PubMed lists PMID 39427438 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2024-10-17 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa`](#source-pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa`](#source-pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa))

### Sources

<a id="source-pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa"></a>
- **Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS. · retained source version 1:2026-01-27:current:1250dc49dffa5130d87d577cd04d1737803d113e0ec13801f6317ec64b38205f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39427438/) (`pubmed-observation-pmid-39427438-2026-01-27-1250dc49dffa`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39427438-linaclotide-v1 SHA-256: f24564a5636f424601fc0fe8d9349465f3f69dd33c0d9b8c869a15df910e1b5e.

---

<a id="pubmed-pmid-39527338-linaclotide-v1"></a>

## PubMed record PMID 39527338

> PeptideScanner retained PubMed bibliographic metadata for PMID 39527338 at 2026-07-30T16:14:08.881Z. PubMed recorded a metadata revision date of 2026-06-23 and an Entrez history date of 2024-11-11. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39527338-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39527338-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39527338-linaclotide-v1
- Content SHA-256: `aae014099eee2c3b810e7d1c06033647650ce02d44010122efd3d1dc65f4e209`

### Claims and source pins

#### Headline

PubMed record PMID 39527338 ([`pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b`](#source-pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39527338 at 2026-07-30T16:14:08.881Z. PubMed recorded a metadata revision date of 2026-06-23 and an Entrez history date of 2024-11-11. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b`](#source-pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39527338 at 2026-07-30T16:14:08.881Z. PubMed recorded a metadata revision date of 2026-06-23 and an Entrez history date of 2024-11-11. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b`](#source-pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b`](#source-pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b))

### Sources

<a id="source-pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b"></a>
- **PubMed record PMID 39527338 · retained source version 1:2026-06-23:current:fffbc9c2787bee1b8f94fb6c46097c83e5f0e07bb42c6ccc6ffaf012e8edb423** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39527338/) (`pubmed-observation-pmid-39527338-2026-06-23-fffbc9c2787b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39527338." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39527338-linaclotide-v1 SHA-256: aae014099eee2c3b810e7d1c06033647650ce02d44010122efd3d1dc65f4e209.

---

<a id="pubmed-pmid-39530977-linaclotide-v1"></a>

## Linaclotide as a Single Agent Bowel Preparation Regimen Before Colonoscopy.

> PubMed lists PMID 39530977 in The American surgeon as Journal Article, with publication-date metadata of 2024-11-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39530977-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-09-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39530977-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39530977-linaclotide-v1
- Content SHA-256: `ee24d7bc05dcec42d6fc913b8c69e470f78dca13e040a7a7f94b36a427d2e9a6`

### Claims and source pins

#### Headline

Linaclotide as a Single Agent Bowel Preparation Regimen Before Colonoscopy. ([`pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e`](#source-pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e))

#### Summary

PubMed lists PMID 39530977 in The American surgeon as Journal Article, with publication-date metadata of 2024-11-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e`](#source-pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e))

#### Paragraph 1

PubMed lists PMID 39530977 in The American surgeon as Journal Article, with publication-date metadata of 2024-11-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e`](#source-pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e`](#source-pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e))

### Sources

<a id="source-pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e"></a>
- **Linaclotide as a Single Agent Bowel Preparation Regimen Before Colonoscopy. · retained source version 1:2025-09-11:current:4465a50ffe9ea288cd9d2dc35b6a736a8269da30c743ee7431d85909c6ac4eff** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39530977/) (`pubmed-observation-pmid-39530977-2025-09-11-4465a50ffe9e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide as a Single Agent Bowel Preparation Regimen Before Colonoscopy." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39530977-linaclotide-v1 SHA-256: ee24d7bc05dcec42d6fc913b8c69e470f78dca13e040a7a7f94b36a427d2e9a6.

---

<a id="pubmed-pmid-39620387-linaclotide-v1"></a>

## Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis.

> PubMed lists PMID 39620387 in Pediatric pulmonology as Journal Article, with publication-date metadata of 2024-12-02 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39620387-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-05-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39620387-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39620387-linaclotide-v1
- Content SHA-256: `068d1fd8b435d50734e37b5c8725171a978d0b96612c6195756051a8fa97e2c3`

### Claims and source pins

#### Headline

Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis. ([`pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33`](#source-pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33))

#### Summary

PubMed lists PMID 39620387 in Pediatric pulmonology as Journal Article, with publication-date metadata of 2024-12-02 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33`](#source-pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33))

#### Paragraph 1

PubMed lists PMID 39620387 in Pediatric pulmonology as Journal Article, with publication-date metadata of 2024-12-02 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33`](#source-pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33`](#source-pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33))

### Sources

<a id="source-pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33"></a>
- **Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis. · retained source version 1:2025-05-17:current:b7774b6bef333f096d128548eb1cf5e768dd609d4ee548b58ac5afea78bec7c8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39620387/) (`pubmed-observation-pmid-39620387-2025-05-17-b7774b6bef33`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-39620387-linaclotide-v1 SHA-256: 068d1fd8b435d50734e37b5c8725171a978d0b96612c6195756051a8fa97e2c3.

---

<a id="pubmed-pmid-40423516-linaclotide-v1"></a>

## PubMed record PMID 40423516

> PeptideScanner retained PubMed bibliographic metadata for PMID 40423516 at 2026-07-30T16:23:36.824Z. PubMed recorded a metadata revision date of 2026-03-26 and an Entrez history date of 2025-05-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40423516-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-03-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40423516-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-40423516-linaclotide-v1
- Content SHA-256: `de4fe8a911deb4afa3d4cf1980de66eda454924b17cf5b1c9ee6cba00affa65f`

### Claims and source pins

#### Headline

PubMed record PMID 40423516 ([`pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e`](#source-pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40423516 at 2026-07-30T16:23:36.824Z. PubMed recorded a metadata revision date of 2026-03-26 and an Entrez history date of 2025-05-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e`](#source-pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40423516 at 2026-07-30T16:23:36.824Z. PubMed recorded a metadata revision date of 2026-03-26 and an Entrez history date of 2025-05-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e`](#source-pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e`](#source-pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e))

### Sources

<a id="source-pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e"></a>
- **PubMed record PMID 40423516 · retained source version 1:2026-03-26:current:9d4cb4adec5e9ff7270e5cc9a3cf6a866d436cd8b77d2c5d7c9b16ed8c3b26fb** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40423516/) (`pubmed-observation-pmid-40423516-2026-03-26-9d4cb4adec5e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40423516." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-40423516-linaclotide-v1 SHA-256: de4fe8a911deb4afa3d4cf1980de66eda454924b17cf5b1c9ee6cba00affa65f.

---

<a id="pubmed-pmid-41123247-linaclotide-v1"></a>

## PubMed record PMID 41123247

> PeptideScanner retained PubMed bibliographic metadata for PMID 41123247 at 2026-07-30T16:22:16.181Z. PubMed recorded a metadata revision date of 2026-04-10 and an Entrez history date of 2025-10-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41123247-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41123247-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41123247-linaclotide-v1
- Content SHA-256: `71670b0d7bc613d7fd91b4c6d6ca8ff2cc69762df3665b4bf2e15f2b75b1d5e6`

### Claims and source pins

#### Headline

PubMed record PMID 41123247 ([`pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20`](#source-pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41123247 at 2026-07-30T16:22:16.181Z. PubMed recorded a metadata revision date of 2026-04-10 and an Entrez history date of 2025-10-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20`](#source-pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41123247 at 2026-07-30T16:22:16.181Z. PubMed recorded a metadata revision date of 2026-04-10 and an Entrez history date of 2025-10-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20`](#source-pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20`](#source-pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20))

### Sources

<a id="source-pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20"></a>
- **PubMed record PMID 41123247 · retained source version 1:2026-04-10:current:42fc9a312d20ec294df9b938623b9ef58a5a2df911d7e8c2cf5a063517cbb19c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41123247/) (`pubmed-observation-pmid-41123247-2026-04-10-42fc9a312d20`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41123247." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41123247-linaclotide-v1 SHA-256: 71670b0d7bc613d7fd91b4c6d6ca8ff2cc69762df3665b4bf2e15f2b75b1d5e6.

---

<a id="pubmed-pmid-41413756-linaclotide-v1"></a>

## PubMed record PMID 41413756

> PeptideScanner retained PubMed bibliographic metadata for PMID 41413756 at 2026-07-30T16:14:13.037Z. PubMed recorded a metadata revision date of 2026-06-05 and an Entrez history date of 2025-12-18. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41413756-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41413756-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41413756-linaclotide-v1
- Content SHA-256: `86ff7f15c7131e2c093c456b15e0b5202376061458a46aaa5f92a3ea5dc306e9`

### Claims and source pins

#### Headline

PubMed record PMID 41413756 ([`pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09`](#source-pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41413756 at 2026-07-30T16:14:13.037Z. PubMed recorded a metadata revision date of 2026-06-05 and an Entrez history date of 2025-12-18. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09`](#source-pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41413756 at 2026-07-30T16:14:13.037Z. PubMed recorded a metadata revision date of 2026-06-05 and an Entrez history date of 2025-12-18. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09`](#source-pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09`](#source-pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09))

### Sources

<a id="source-pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09"></a>
- **PubMed record PMID 41413756 · retained source version 1:2026-06-05:current:527b0e1a2e095a03369c4034c186863b26e4feb4b27b37844ce8a7022ef39033** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41413756/) (`pubmed-observation-pmid-41413756-2026-06-05-527b0e1a2e09`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41413756." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41413756-linaclotide-v1 SHA-256: 86ff7f15c7131e2c093c456b15e0b5202376061458a46aaa5f92a3ea5dc306e9.

---

<a id="pubmed-pmid-41539984-linaclotide-v1"></a>

## PubMed record PMID 41539984

> PeptideScanner retained PubMed bibliographic metadata for PMID 41539984 at 2026-07-30T16:14:14.760Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41539984-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41539984-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41539984-linaclotide-v1
- Content SHA-256: `ccef3b042df85d644ef74bfecf5593b779fc0e982e1ad22a19346cc1e7caacc9`

### Claims and source pins

#### Headline

PubMed record PMID 41539984 ([`pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e`](#source-pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41539984 at 2026-07-30T16:14:14.760Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e`](#source-pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41539984 at 2026-07-30T16:14:14.760Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e`](#source-pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e`](#source-pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e))

### Sources

<a id="source-pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e"></a>
- **PubMed record PMID 41539984 · retained source version 1:2026-06-26:current:071eecb8af8edb9da11c8b403632e8141cc03acfc36843254dc301ef9d997a52** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41539984/) (`pubmed-observation-pmid-41539984-2026-06-26-071eecb8af8e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41539984." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41539984-linaclotide-v1 SHA-256: ccef3b042df85d644ef74bfecf5593b779fc0e982e1ad22a19346cc1e7caacc9.

---

<a id="pubmed-pmid-41692643-linaclotide-v1"></a>

## PubMed record PMID 41692643

> PeptideScanner retained PubMed bibliographic metadata for PMID 41692643 at 2026-08-10T10:49:08.765Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41692643-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-03
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41692643-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41692643-linaclotide-v1
- Content SHA-256: `08e37fcb376fab5fbe6e4d918b4516191a695d3dd3c9526c5df16a8ce7197caa`

### Claims and source pins

#### Headline

PubMed record PMID 41692643 ([`pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2`](#source-pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41692643 at 2026-08-10T10:49:08.765Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2`](#source-pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41692643 at 2026-08-10T10:49:08.765Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2`](#source-pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2`](#source-pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2))

### Sources

<a id="source-pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2"></a>
- **PubMed record PMID 41692643 · retained source version 1:2026-08-03:current:e1f1bc864de2bc1208a6c5bbad14efcebb0c44b5bb2b951f3503c2b550194e89** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41692643/) (`pubmed-observation-pmid-41692643-2026-08-03-e1f1bc864de2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41692643." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41692643-linaclotide-v1 SHA-256: 08e37fcb376fab5fbe6e4d918b4516191a695d3dd3c9526c5df16a8ce7197caa.

---

<a id="pubmed-pmid-41913506-linaclotide-v1"></a>

## PubMed record PMID 41913506

> PeptideScanner retained PubMed bibliographic metadata for PMID 41913506 at 2026-08-10T18:13:46.784Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-03-31. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41913506-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-28
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41913506-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41913506-linaclotide-v1
- Content SHA-256: `12841ce2041a4f3bfaa8d06f534ec601b1f35c538518566faa134c1645508285`

### Claims and source pins

#### Headline

PubMed record PMID 41913506 ([`pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a`](#source-pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41913506 at 2026-08-10T18:13:46.784Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-03-31. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a`](#source-pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41913506 at 2026-08-10T18:13:46.784Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-03-31. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a`](#source-pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a`](#source-pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a))

### Sources

<a id="source-pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a"></a>
- **PubMed record PMID 41913506 · retained source version 1:2026-07-28:current:2398ae1fa06ad5730716a081242f3213ef3d19cd4f25e3d88a1209501071289d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41913506/) (`pubmed-observation-pmid-41913506-2026-07-28-2398ae1fa06a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41913506." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-41913506-linaclotide-v1 SHA-256: 12841ce2041a4f3bfaa8d06f534ec601b1f35c538518566faa134c1645508285.

---

<a id="pubmed-pmid-42009975-linaclotide-v1"></a>

## PubMed record PMID 42009975

> PeptideScanner retained PubMed bibliographic metadata for PMID 42009975 at 2026-08-10T18:13:48.763Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42009975-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-26
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42009975-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42009975-linaclotide-v1
- Content SHA-256: `bb2abda6f81117ef741e89d96a1bca29adbd2b95510c150770d10b9e68a41f91`

### Claims and source pins

#### Headline

PubMed record PMID 42009975 ([`pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c`](#source-pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42009975 at 2026-08-10T18:13:48.763Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c`](#source-pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42009975 at 2026-08-10T18:13:48.763Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c`](#source-pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c`](#source-pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c))

### Sources

<a id="source-pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c"></a>
- **PubMed record PMID 42009975 · retained source version 1:2026-07-26:current:acf128d07a6cc8ebb1f0e952fa6654e5619cfd61f16c19205c3108346d6db663** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42009975/) (`pubmed-observation-pmid-42009975-2026-07-26-acf128d07a6c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42009975." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42009975-linaclotide-v1 SHA-256: bb2abda6f81117ef741e89d96a1bca29adbd2b95510c150770d10b9e68a41f91.

---

<a id="pubmed-pmid-42083746-linaclotide-v1"></a>

## PubMed record PMID 42083746

> PeptideScanner retained PubMed bibliographic metadata for PMID 42083746 at 2026-08-10T18:13:48.845Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42083746-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-16
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42083746-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42083746-linaclotide-v1
- Content SHA-256: `83decf8caa7d126b7658ad535ddf607a1aa4aaa271bf47f2e2b1785deaf04972`

### Claims and source pins

#### Headline

PubMed record PMID 42083746 ([`pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4`](#source-pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42083746 at 2026-08-10T18:13:48.845Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4`](#source-pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42083746 at 2026-08-10T18:13:48.845Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4`](#source-pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4`](#source-pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4))

### Sources

<a id="source-pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4"></a>
- **PubMed record PMID 42083746 · retained source version 1:2026-07-16:current:74a7839340d4c458159f7a38a88bedb36b5a37571d751626545b2db583c53c06** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42083746/) (`pubmed-observation-pmid-42083746-2026-07-16-74a7839340d4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42083746." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42083746-linaclotide-v1 SHA-256: 83decf8caa7d126b7658ad535ddf607a1aa4aaa271bf47f2e2b1785deaf04972.

---

<a id="pubmed-pmid-42425925-linaclotide-v1"></a>

## PubMed record PMID 42425925

> PeptideScanner retained PubMed bibliographic metadata for PMID 42425925 at 2026-08-10T10:49:10.758Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42425925-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-03
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42425925-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42425925-linaclotide-v1
- Content SHA-256: `85a7b47d0b1db990add422f1ccb589f4cf5243530763f7b249b1531a658c8bd5`

### Claims and source pins

#### Headline

PubMed record PMID 42425925 ([`pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707`](#source-pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42425925 at 2026-08-10T10:49:10.758Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707`](#source-pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42425925 at 2026-08-10T10:49:10.758Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707`](#source-pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707`](#source-pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707))

### Sources

<a id="source-pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707"></a>
- **PubMed record PMID 42425925 · retained source version 1:2026-08-03:current:b54788ff3707e7c95cb722c109f3b561a737b6d84989f051f748877cef370fe4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42425925/) (`pubmed-observation-pmid-42425925-2026-08-03-b54788ff3707`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42425925." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42425925-linaclotide-v1 SHA-256: 85a7b47d0b1db990add422f1ccb589f4cf5243530763f7b249b1531a658c8bd5.

---

<a id="pubmed-pmid-42465095-linaclotide-v1"></a>

## PubMed record PMID 42465095

> PeptideScanner retained PubMed bibliographic metadata for PMID 42465095 at 2026-08-10T18:13:55.292Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-07-17. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42465095-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-17
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42465095-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42465095-linaclotide-v1
- Content SHA-256: `6deaa9d88bfd60c0f0f420891320c34fdee8c6805002a3a187fac52c3ca00c22`

### Claims and source pins

#### Headline

PubMed record PMID 42465095 ([`pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8`](#source-pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42465095 at 2026-08-10T18:13:55.292Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-07-17. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8`](#source-pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42465095 at 2026-08-10T18:13:55.292Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-07-17. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8`](#source-pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8`](#source-pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8))

### Sources

<a id="source-pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8"></a>
- **PubMed record PMID 42465095 · retained source version 1:2026-07-17:current:9192bc67a4e8d5984aee730c30c33046d638f2d47b22dafa994f327a1ce72d00** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42465095/) (`pubmed-observation-pmid-42465095-2026-07-17-9192bc67a4e8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42465095." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42465095-linaclotide-v1 SHA-256: 6deaa9d88bfd60c0f0f420891320c34fdee8c6805002a3a187fac52c3ca00c22.

---

<a id="pubmed-pmid-42482900-linaclotide-v1"></a>

## PubMed record PMID 42482900

> PeptideScanner retained PubMed bibliographic metadata for PMID 42482900 at 2026-08-10T18:13:56.703Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42482900-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-22
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42482900-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42482900-linaclotide-v1
- Content SHA-256: `8fc4f74681ed6fd703f9b8e535bd8a4b5f107b6793e276538cfbcc5b60cced8e`

### Claims and source pins

#### Headline

PubMed record PMID 42482900 ([`pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a`](#source-pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42482900 at 2026-08-10T18:13:56.703Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a`](#source-pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42482900 at 2026-08-10T18:13:56.703Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a`](#source-pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a`](#source-pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a))

### Sources

<a id="source-pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a"></a>
- **PubMed record PMID 42482900 · retained source version 1:2026-07-22:current:c4cd0e67803a8d43b9bb6c6015b1aa8f25e6a70dc095fee6f1f2ea3055dffeb7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42482900/) (`pubmed-observation-pmid-42482900-2026-07-22-c4cd0e67803a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42482900." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42482900-linaclotide-v1 SHA-256: 8fc4f74681ed6fd703f9b8e535bd8a4b5f107b6793e276538cfbcc5b60cced8e.

---

<a id="pubmed-pmid-42523615-linaclotide-v1"></a>

## PubMed record PMID 42523615

> PeptideScanner retained PubMed bibliographic metadata for PMID 42523615 at 2026-08-10T18:13:56.783Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42523615-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-29
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42523615-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42523615-linaclotide-v1
- Content SHA-256: `fd7f38a68568d5f75b6c257a7cb2a08684c83a83df5841e7677783a078c78351`

### Claims and source pins

#### Headline

PubMed record PMID 42523615 ([`pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568`](#source-pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42523615 at 2026-08-10T18:13:56.783Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568`](#source-pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42523615 at 2026-08-10T18:13:56.783Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568`](#source-pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568`](#source-pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568))

### Sources

<a id="source-pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568"></a>
- **PubMed record PMID 42523615 · retained source version 1:2026-07-29:current:c8ee1a8075686650e484cb90b6172ddcae6ff177bfc9de1c7fc0879eb59cce3c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42523615/) (`pubmed-observation-pmid-42523615-2026-07-29-c8ee1a807568`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42523615." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/linaclotide.json#pubmed-pmid-42523615-linaclotide-v1 SHA-256: fd7f38a68568d5f75b6c257a7cb2a08684c83a83df5841e7677783a078c78351.

